<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD v1.0 20120330//EN" "JATS-archivearticle1.dtd">
<article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="research-article"><?properties open_access?><front><journal-meta><journal-id journal-id-type="nlm-ta">PLoS One</journal-id><journal-id journal-id-type="iso-abbrev">PLoS ONE</journal-id><journal-id journal-id-type="publisher-id">plos</journal-id><journal-id journal-id-type="pmc">plosone</journal-id><journal-title-group><journal-title>PLoS ONE</journal-title></journal-title-group><issn pub-type="epub">1932-6203</issn><publisher><publisher-name>Public Library of Science</publisher-name><publisher-loc>San Francisco, CA USA</publisher-loc></publisher></journal-meta><article-meta><article-id pub-id-type="pmid">27537847</article-id><article-id pub-id-type="pmc">4990252</article-id><article-id pub-id-type="doi">10.1371/journal.pone.0161400</article-id><article-id pub-id-type="publisher-id">PONE-D-16-04288</article-id><article-categories><subj-group subj-group-type="heading"><subject>Research Article</subject></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Biology and Life Sciences</subject><subj-group><subject>Biochemistry</subject><subj-group><subject>Lipids</subject><subj-group><subject>Fats</subject></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Biology and Life Sciences</subject><subj-group><subject>Physiology</subject><subj-group><subject>Physiological Parameters</subject><subj-group><subject>Body Weight</subject><subj-group><subject>Obesity</subject></subj-group></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Medicine and Health Sciences</subject><subj-group><subject>Physiology</subject><subj-group><subject>Physiological Parameters</subject><subj-group><subject>Body Weight</subject><subj-group><subject>Obesity</subject></subj-group></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Biology and Life Sciences</subject><subj-group><subject>Cell Biology</subject><subj-group><subject>Oxidative Stress</subject></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Medicine and Health Sciences</subject><subj-group><subject>Endocrinology</subject><subj-group><subject>Diabetic Endocrinology</subject><subj-group><subject>Insulin</subject></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Biology and Life Sciences</subject><subj-group><subject>Biochemistry</subject><subj-group><subject>Hormones</subject><subj-group><subject>Insulin</subject></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Medicine and Health Sciences</subject><subj-group><subject>Endocrinology</subject><subj-group><subject>Endocrine Physiology</subject><subj-group><subject>Insulin Resistance</subject></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Biology and Life Sciences</subject><subj-group><subject>Physiology</subject><subj-group><subject>Endocrine Physiology</subject><subj-group><subject>Insulin Resistance</subject></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Medicine and Health Sciences</subject><subj-group><subject>Physiology</subject><subj-group><subject>Endocrine Physiology</subject><subj-group><subject>Insulin Resistance</subject></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Biology and Life Sciences</subject><subj-group><subject>Biochemistry</subject><subj-group><subject>Proteins</subject><subj-group><subject>Lipoproteins</subject></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Biology and Life Sciences</subject><subj-group><subject>Biochemistry</subject><subj-group><subject>Lipids</subject><subj-group><subject>Cholesterol</subject></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Physical Sciences</subject><subj-group><subject>Chemistry</subject><subj-group><subject>Chemical Compounds</subject><subj-group><subject>Organic Compounds</subject><subj-group><subject>Carbohydrates</subject><subj-group><subject>Monosaccharides</subject><subj-group><subject>Glucose</subject></subj-group></subj-group></subj-group></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Physical Sciences</subject><subj-group><subject>Chemistry</subject><subj-group><subject>Organic Chemistry</subject><subj-group><subject>Organic Compounds</subject><subj-group><subject>Carbohydrates</subject><subj-group><subject>Monosaccharides</subject><subj-group><subject>Glucose</subject></subj-group></subj-group></subj-group></subj-group></subj-group></subj-group></subj-group></article-categories><title-group><article-title>Unsaturated Oral Fat Load Test Improves Glycemia, Insulinemia and Oxidative Stress Status in Nondiabetic Subjects with Abdominal Obesity</article-title><alt-title alt-title-type="running-head">Unsaturated Oral Fat Load Test and Abdominal Obesity</alt-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>Martinez-Hervas</surname><given-names>Sergio</given-names></name><xref ref-type="aff" rid="aff001"><sup>1</sup></xref><xref ref-type="aff" rid="aff002"><sup>2</sup></xref><xref ref-type="aff" rid="aff003"><sup>3</sup></xref></contrib><contrib contrib-type="author"><name><surname>Navarro</surname><given-names>Inmaculada</given-names></name><xref ref-type="aff" rid="aff001"><sup>1</sup></xref></contrib><contrib contrib-type="author"><name><surname>Real</surname><given-names>Jose T.</given-names></name><xref ref-type="aff" rid="aff001"><sup>1</sup></xref><xref ref-type="aff" rid="aff002"><sup>2</sup></xref><xref ref-type="aff" rid="aff003"><sup>3</sup></xref><xref ref-type="corresp" rid="cor001">*</xref></contrib><contrib contrib-type="author"><name><surname>Artero</surname><given-names>Ana</given-names></name><xref ref-type="aff" rid="aff001"><sup>1</sup></xref></contrib><contrib contrib-type="author"><name><surname>Peiro</surname><given-names>Marta</given-names></name><xref ref-type="aff" rid="aff003"><sup>3</sup></xref><xref ref-type="aff" rid="aff004"><sup>4</sup></xref></contrib><contrib contrib-type="author"><name><surname>Gonzalez-Navarro</surname><given-names>Herminia</given-names></name><xref ref-type="aff" rid="aff003"><sup>3</sup></xref><xref ref-type="aff" rid="aff004"><sup>4</sup></xref></contrib><contrib contrib-type="author"><name><surname>Carmena</surname><given-names>Rafael</given-names></name><xref ref-type="aff" rid="aff002"><sup>2</sup></xref><xref ref-type="aff" rid="aff003"><sup>3</sup></xref><xref ref-type="aff" rid="aff004"><sup>4</sup></xref></contrib><contrib contrib-type="author"><name><surname>Ascaso</surname><given-names>Juan F.</given-names></name><xref ref-type="aff" rid="aff001"><sup>1</sup></xref><xref ref-type="aff" rid="aff002"><sup>2</sup></xref><xref ref-type="aff" rid="aff003"><sup>3</sup></xref></contrib></contrib-group><aff id="aff001"><label>1</label><addr-line>Service of Endocrinology and Nutrition, Hospital Cl&#x000ed;nico Universitario Valencia, Valencia, Spain</addr-line></aff><aff id="aff002"><label>2</label><addr-line>Department of Medicine, University of Valencia, Valencia, Spain</addr-line></aff><aff id="aff003"><label>3</label><addr-line>CIBER of Diabetes and Associated Metabolic Diseases (CIBERDEM), ISCIII, Madrid, Spain</addr-line></aff><aff id="aff004"><label>4</label><addr-line>Hospital Cl&#x000ed;nico Research Foundation (INCLIVA), Valencia, Spain</addr-line></aff><contrib-group><contrib contrib-type="editor"><name><surname>Folli</surname><given-names>Franco</given-names></name><role>Editor</role><xref ref-type="aff" rid="edit1"/></contrib></contrib-group><aff id="edit1"><addr-line>University of Texas Health Science Center at San Antonio, UNITED STATES</addr-line></aff><author-notes><fn fn-type="conflict" id="coi001"><p><bold>Competing Interests: </bold>The authors have declared that no competing interests exist.</p></fn><fn fn-type="con"><p><list list-type="simple"><list-item><p><bold>Conceived and designed the experiments:</bold> SMH JTR JFA.</p></list-item><list-item><p><bold>Performed the experiments:</bold> MP HGN.</p></list-item><list-item><p><bold>Analyzed the data:</bold> SMH JTR JFA.</p></list-item><list-item><p><bold>Wrote the paper:</bold> SMH JTR JFA.</p></list-item><list-item><p>Contributed to the performance of the clinical study: SMH JTR JFA IN AA RC.</p></list-item></list>
</p></fn><corresp id="cor001">* E-mail: <email>jtreal@uv.es</email></corresp></author-notes><pub-date pub-type="epub"><day>18</day><month>8</month><year>2016</year></pub-date><pub-date pub-type="collection"><year>2016</year></pub-date><volume>11</volume><issue>8</issue><elocation-id>e0161400</elocation-id><history><date date-type="received"><day>30</day><month>1</month><year>2016</year></date><date date-type="accepted"><day>4</day><month>8</month><year>2016</year></date></history><permissions><copyright-statement>&#x000a9; 2016 Martinez-Hervas et al</copyright-statement><copyright-year>2016</copyright-year><copyright-holder>Martinez-Hervas et al</copyright-holder><license xlink:href="http://creativecommons.org/licenses/by/4.0/"><license-p>This is an open access article distributed under the terms of the <ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/4.0/">Creative Commons Attribution License</ext-link>, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.</license-p></license></permissions><self-uri content-type="pdf" xlink:href="pone.0161400.pdf"/><abstract><sec id="sec001"><title>Aims</title><p>To evaluate the changes in glycemia, insulinemia, and oxidative stress markers during an oral fat load test in nondiabetic subjects with abdominal obesity and to analyze the association between postprandial oxidative stress markers and postprandial glucose and insulin responses.</p></sec><sec id="sec002"><title>Methods</title><p>We included 20 subjects with abdominal obesity (waist circumference &#x0003e; 102 cm for men and &#x0003e; 88 cm for women) and 20 healthy lean controls (waist circumference &#x0003c; 102 cm for men and &#x0003c; 88 cm for women). After 12 hours of fasting we performed a standardized fat load test (0&#x02013;8 hours) with supracal<sup>&#x000ae;</sup> (50 g/m<sup>2</sup>). We determined metabolic parameters, oxidized and reduced glutathione, and malondialdehyde.</p></sec><sec id="sec003"><title>Results</title><p>In both groups, insulin, HOMA, oxidized/reduced glutathione ratio, and malondialdehyde significantly decreased in the postprandial state after the OFLT. All these parameters were significantly higher in the abdominal obesity group at baseline and during all the postprandial points, but the reduction from the baseline levels was significantly higher in the abdominal obesity group.</p></sec><sec id="sec004"><title>Conclusion</title><p>Unsaturated fat improves insulin resistance and oxidative stress status. It is possible that a consumption of unsaturated fat could be beneficial even in subjects with abdominal obesity in postprandial state.</p></sec></abstract><funding-group><award-group id="award001"><funding-source><institution-wrap><institution-id institution-id-type="funder-id">http://dx.doi.org/10.13039/501100004587</institution-id><institution>Instituto de Salud Carlos III</institution></institution-wrap></funding-source><award-id>FIS 10/0051</award-id><principal-award-recipient><name><surname>Ascaso</surname><given-names>Juan F.</given-names></name></principal-award-recipient></award-group><award-group id="award002"><funding-source><institution-wrap><institution-id institution-id-type="funder-id">http://dx.doi.org/10.13039/501100004587</institution-id><institution>Instituto de Salud Carlos III</institution></institution-wrap></funding-source><award-id>FIS 05/0348</award-id><principal-award-recipient><name><surname>Real</surname><given-names>Jose T.</given-names></name></principal-award-recipient></award-group><award-group id="award003"><funding-source><institution-wrap><institution-id institution-id-type="funder-id">http://dx.doi.org/10.13039/501100004587</institution-id><institution>Instituto de Salud Carlos III</institution></institution-wrap></funding-source><award-id>FIS 12/01978</award-id><principal-award-recipient><name><surname>Real</surname><given-names>Jose T.</given-names></name></principal-award-recipient></award-group><award-group id="award004"><funding-source><institution-wrap><institution-id institution-id-type="funder-id">http://dx.doi.org/10.13039/501100003359</institution-id><institution>Generalitat Valenciana</institution></institution-wrap></funding-source><award-id>GE-010/09</award-id><principal-award-recipient><name><surname>Martinez-Hervas</surname><given-names>Sergio</given-names></name></principal-award-recipient></award-group><award-group id="award005"><funding-source><institution>CIBERDEM</institution></funding-source></award-group><funding-statement>This work has been supported by grants from Fondo de Investigaciones Sanitarias to Juan F. Ascaso T (FIS 10/0051), Jose T. Real (FIS 05/0348, FIS 12/01978) and CIBER de Diabetes y Enfermedades Metab&#x000f3;licas Asociadas, and from the Valencian Government to Sergio Martinez-Hervas (GE-010/09).</funding-statement></funding-group><counts><fig-count count="1"/><table-count count="4"/><page-count count="11"/></counts><custom-meta-group><custom-meta id="data-availability"><meta-name>Data Availability</meta-name><meta-value>All relevant data are within the paper and its Supporting Information file.</meta-value></custom-meta></custom-meta-group></article-meta><notes><title>Data Availability</title><p>All relevant data are within the paper and its Supporting Information file.</p></notes></front><body><sec sec-type="intro" id="sec005"><title>Introduction</title><p>Obesity and overweight are increasing health problems worldwide. It is estimated that more than 60% of all adults in the United States are overweight or obese [<xref rid="pone.0161400.ref001" ref-type="bibr">1</xref>]. Both conditions are closely associated with several metabolic complications [<xref rid="pone.0161400.ref002" ref-type="bibr">2</xref>]. The excess of body fat and particularly the visceral deposits of fat, classically known as abdominal obesity, are associated with insulin resistance (IR), impaired glucose metabolism and type 2 diabetes mellitus, as well as atherogenic dyslipidemia [<xref rid="pone.0161400.ref003" ref-type="bibr">3</xref>]. Moreover, obesity, in humans and in experimental models, is associated with enhanced fasting and postprandial oxidative stress [<xref rid="pone.0161400.ref004" ref-type="bibr">4</xref>]. Oxidative stress is also observed in conditions affecting the cardiovascular system like smoking, dyslipemia, diabetes and hypertension [<xref rid="pone.0161400.ref005" ref-type="bibr">5</xref>]. It is considered that oxidative stress may lead to many cellular events, such as inactivation of nitric oxidase, oxidative modifications of DNA and proteins, lipid oxidation, enhanced mitogenicity and apoptosis of cells that contribute to the development and progression of IR [<xref rid="pone.0161400.ref006" ref-type="bibr">6</xref>].</p><p>In the last decade, dietary habits have changed and the number of meals has increased. Thus the majority of individuals spend most of the day in a postprandial state. Postprandial lipemia (PL) is determined by the accumulation in plasma of triglyceride-rich lipoproteins (TRL) such as chylomicrons (QM), and very low density lipoproteins (VLDL) between 6&#x02013;10 hours following a meal [<xref rid="pone.0161400.ref007" ref-type="bibr">7</xref>]. In subjects with abdominal obesity, diabetes and metabolic syndrome, the postprandial impaired clearance of lipoproteins appears to be exaggerated and this situation is related to the grade of IR [<xref rid="pone.0161400.ref008" ref-type="bibr">8</xref>].</p><p>Postprandial oxidative stress status is also altered in obese patients [<xref rid="pone.0161400.ref004" ref-type="bibr">4</xref>]. In addition, in the postprandial state, circulating lipids and lipoproteins can modulate oxidative stress status. Several fat meal test, dietary intervention and oral fat load tests (OFLT) on healthy population have shown that the type of fat can regulate oxidative stress status, such as modulation of the oxidative/antioxidative status and improve of endothelial function [<xref rid="pone.0161400.ref009" ref-type="bibr">9</xref>]. Beneficial effects have been shown when unsaturated fat was used compared to saturated fat [<xref rid="pone.0161400.ref010" ref-type="bibr">10</xref>,<xref rid="pone.0161400.ref011" ref-type="bibr">11</xref>]. However, scarce evidence exists about the effect of different quality of fats on oxidative stress in subjects with abdominal obesity [<xref rid="pone.0161400.ref012" ref-type="bibr">12</xref>].</p><p>In summary, subjects with abdominal obesity present fasting IR, altered PL and fasting and postprandial oxidative stress. Dietary saturated fat can increase fasting IR and altered PL in such subjects. Postprandial altered oxidative stress in abdominal obesity subjects can be related to dietary fat intake. However, the postprandial response of glycemia, insulinemia and its relation to postprandial oxidative stress markers in abdominal obesity subjects is not well known. Thus the aims of our study were to evaluate the changes in glycemia, insulinemia and oxidative stress markers during an OFLT in nondiabetic subjects with abdominal obesity and to analyze the association between postprandial oxidative stress markers and postprandial glucose and insulin responses.</p></sec><sec id="sec006"><title>Subjects and Methods</title><sec id="sec007"><title>Subjects</title><p>We have studied 20 healthy volunteer subjects (11 males/9 females) and 20 subjects with abdominal obesity (7 males/13 females). All the subjects included in the study were non-hypertensive, non-diabetic, non-smokers, and had no clinical manifestations of cardiovascular disease and were off-treatment. Fasting plasma glucose was &#x0003c;100 mg/dl and HbA1c was &#x0003c; 5.7%. All the subjects included in the study had a previous OGTT. In all of the cases glucose was &#x0003c;140 mg/dl (<xref ref-type="table" rid="pone.0161400.t001">Table 1</xref>). Their BMI was below 35 kg/m<sup>2</sup> and their age range was between 18 and 65 years.</p><table-wrap id="pone.0161400.t001" orientation="portrait" position="float"><object-id pub-id-type="doi">10.1371/journal.pone.0161400.t001</object-id><label>Table 1</label><caption><title>General characteristics, fasting lipids and lipoproteins, glucose, insulin and HOMA index values in the studied groups.</title></caption><alternatives><graphic id="pone.0161400.t001g" xlink:href="pone.0161400.t001"/><table frame="hsides" rules="groups"><colgroup span="1"><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/></colgroup><thead><tr><th align="justify" rowspan="1" colspan="1"/><th align="center" rowspan="1" colspan="1">Control group (n = 20)</th><th align="center" rowspan="1" colspan="1">Abdominal obesity group (n = 20)</th></tr></thead><tbody><tr><td align="justify" rowspan="1" colspan="1"><bold>Gender (M/F)</bold></td><td align="center" rowspan="1" colspan="1">11/9</td><td align="center" rowspan="1" colspan="1">7/13</td></tr><tr><td align="justify" rowspan="1" colspan="1"><bold>Age (years)</bold></td><td align="center" rowspan="1" colspan="1">38.8&#x000b1;10.1</td><td align="center" rowspan="1" colspan="1">41.0&#x000b1;11.9</td></tr><tr><td align="justify" rowspan="1" colspan="1"><bold>BMI (kg/m</bold><sup><bold>2</bold></sup><bold>)</bold></td><td align="center" rowspan="1" colspan="1">24.4&#x000b1;2.8</td><td align="center" rowspan="1" colspan="1">32.4&#x000b1;4.12 <xref ref-type="table-fn" rid="t001fn001"><sup>a</sup></xref></td></tr><tr><td align="justify" rowspan="1" colspan="1"><bold>Waist circumference (cm)</bold></td><td align="center" rowspan="1" colspan="1">86.7&#x000b1;8.9</td><td align="center" rowspan="1" colspan="1">105.7&#x000b1;11.2 <xref ref-type="table-fn" rid="t001fn001"><sup>a</sup></xref></td></tr><tr><td align="justify" rowspan="1" colspan="1"><bold>TC (mg/dL)</bold></td><td align="center" rowspan="1" colspan="1">178.3&#x000b1;27.9</td><td align="center" rowspan="1" colspan="1">213.0&#x000b1;24.9 <xref ref-type="table-fn" rid="t001fn001"><sup>a</sup></xref></td></tr><tr><td align="justify" rowspan="1" colspan="1"><bold>TG (mg/dL)</bold></td><td align="center" rowspan="1" colspan="1">68.6&#x000b1;21.4</td><td align="center" rowspan="1" colspan="1">132.8&#x000b1;64.6 <xref ref-type="table-fn" rid="t001fn001"><sup>a</sup></xref></td></tr><tr><td align="justify" rowspan="1" colspan="1"><bold>HDL-C (mg/dL)</bold></td><td align="center" rowspan="1" colspan="1">60.3&#x000b1;11.3</td><td align="center" rowspan="1" colspan="1">55.0&#x000b1;10.4</td></tr><tr><td align="justify" rowspan="1" colspan="1"><bold>ApoB (mg/dL)</bold></td><td align="center" rowspan="1" colspan="1">79.2&#x000b1;17.6</td><td align="center" rowspan="1" colspan="1">97.5&#x000b1;13.1 <xref ref-type="table-fn" rid="t001fn001"><sup>a</sup></xref></td></tr><tr><td align="justify" rowspan="1" colspan="1"><bold>Glucose (mg/dL)</bold></td><td align="center" rowspan="1" colspan="1">91.5&#x000b1;8.3</td><td align="center" rowspan="1" colspan="1">92.8&#x000b1;8.6</td></tr><tr><td align="justify" rowspan="1" colspan="1"><bold>Insulin (&#x003bc;U/mL)</bold></td><td align="center" rowspan="1" colspan="1">5.2&#x000b1;2.7</td><td align="center" rowspan="1" colspan="1">19.7&#x000b1;14.2 <xref ref-type="table-fn" rid="t001fn001"><sup>a</sup></xref></td></tr><tr><td align="justify" rowspan="1" colspan="1"><bold>HOMA index</bold></td><td align="center" rowspan="1" colspan="1">1.1&#x000b1;0.6</td><td align="center" rowspan="1" colspan="1">4.6&#x000b1;3.9 <xref ref-type="table-fn" rid="t001fn001"><sup>a</sup></xref></td></tr><tr><td align="justify" rowspan="1" colspan="1"><bold>OGTT: Glucose 0 min (mg/dL)</bold></td><td align="center" rowspan="1" colspan="1">88.6&#x000b1;4.4</td><td align="center" rowspan="1" colspan="1">88.8&#x000b1;4.9</td></tr><tr><td align="justify" rowspan="1" colspan="1"><bold>OGTT: Glucose 120 min (mg/dL)</bold></td><td align="center" rowspan="1" colspan="1">87.2&#x000b1;12.4</td><td align="center" rowspan="1" colspan="1">111.5&#x000b1;13.2 <xref ref-type="table-fn" rid="t001fn001"><sup>a</sup></xref></td></tr></tbody></table></alternatives><table-wrap-foot><fn id="t001fn001"><p><sup>a</sup> p control vs abdominal obesity group (p&#x0003c;0.01).</p></fn><fn id="t001fn002"><p>Abbreviations: BMI = body mass index;F = female; HDL-C = high density lipoprotein cholesterol; M = male; OGTT: oral glucose tolerance test; TC = total cholesterol; TG = triglycerides.</p></fn><fn id="t001fn003"><p>OGTT was performed before the inclusion of the subjects in the present study, in a different day.</p></fn></table-wrap-foot></table-wrap><p>The inclusion criteria for subjects with abdominal obesity were waist circumference &#x0003e;102/88 cm for men and women respectively. The inclusion criteria for subjects included in the control group were: waist circumference &#x0003c;102/88 cm for men and women respectively, total cholesterol (TC) concentration &#x0003c;200mg/dl, triglycerides (TG)&#x0003c;150 mg/dl and apo B &#x0003c;100 mg/dl, with no family history of dyslipidemia, cardiovascular disease or diabetes.</p><p>Exclusion criteria were clinical manifestations of cardiovascular disease, diabetes, hypertension, smoking habit or smoker in the previous year, consumption of &#x0003e; 30 g alcohol/day, intense physical fitness or weight-loss programs, body-weight fluctuation &#x0003e; 10% in the previous 3 months, other chronic diseases, other secondary hyperlipidemias, renal or hepatic insufficiency or hypothyroidism, use of drugs capable of modifying the lipid profile, oxidative stress or inflammation that could not be withdrawn 6 weeks before initiating the study; and any infection or inflammatory disease in the 6 weeks prior to the study.</p><p>The study was approved by the Ethical Committee of Hospital Clinico Universitario de Valencia. All the subjects gave written informed consent to participate in the study.</p></sec><sec id="sec008"><title>Clinical and anthropometric parameters</title><p>In the study protocol the following clinical parameters were recorded: smoking, consumption of alcohol (grams of alcohol per day), physical exercise (hours/week) and use of regular or occasional drugs that could interfere with the study.</p><p>The anthropometric parameters and blood pressure were collected using standardized procedures: weight (kg), height (m), BMI (kg/m<sup>2</sup>), blood pressure (mmHg) and the waist circumference (midpoint between the edge lower rib and iliac crest, in centimetres). All these measurements were done by the same researcher.</p></sec><sec id="sec009"><title>Oral fat load test</title><p>Subjects ingested a commercial liquid preparation of high-fat meal of long chain triglycerides (Supracal; SHS International Ltd; 50 g fat per m<sup>2</sup> of body surface). Each 100 ml contains 50 g of fat (450 Kcal): 9.6 g are saturated, 28.2 g are monounsaturated and 10 g are polyunsaturated. The ratio &#x003c9;6/&#x003c9;3 is &#x0003e; 20/1.</p><p>The study started at 8:30 AM, after a 12 hour overnight fast. Subjects rested for 30 minutes before the first blood sample extraction. After that, the liquid preparation of lipids (Supracal) was administered. The participants remained sitting or supine during 8 hours and were only allowed to drink mineral water. Peripheral blood samples were obtained before (time 0) and at regular time intervals of 2 hours up to 8 hours after the OFLT.</p></sec><sec id="sec010"><title>Laboratory methods</title><sec id="sec011"><title>Measurement of lipids and lipoproteins</title><p>After 12 hours fast, blood samples were drawn from an antecubital vein in tubes containing EDTA (Vacutainer) and were centrifuged within 4 hours. Plasma was stored at 4&#x000b0;C for a maximum of 3 days. Total cholesterol (TC) and triglycerides (TG) levels were measured by standard enzymatic techniques. High density lipoprotein cholesterol (HDL-C) was measured after precipitation of apoB-containing lipoproteins with polyanions and VLDL cholesterol after separation of VLDL (d &#x0003c;1.006 g/mL) by ultracentrifugation. The LDL-C was calculated by subtraction of VLDL and HDL cholesterol from total cholesterol. Total plasma apoB was measured by immunoturbimetry. The coefficients of variation for lipids and lipoproteins were &#x0003c; 5%. Glucose was determined using enzymatic methods. Insulin and c-peptide values were determined using a standardized ELISA. The homeostasis model assessmentindex (HOMA), which is defined as fasting insulin (in microunits per milliliter) &#x000d7; fasting plasma glucose (in millimoles per liter)/22.5was used as index of insulin resistance [<xref rid="pone.0161400.ref013" ref-type="bibr">13</xref>]. All procedures were standard as previously described [<xref rid="pone.0161400.ref014" ref-type="bibr">14</xref>].</p></sec><sec id="sec012"><title>Oxidative stress assays</title><p>Markers of oxidative stress were determined in circulating mononuclear cells isolated by Ficoll-Hypaque methods. Oxidized and reduced glutathione (GSSG and GSH) and MDA were analysed by high-performance liquid columns (HPLC) and UV detection [<xref rid="pone.0161400.ref015" ref-type="bibr">15</xref>,<xref rid="pone.0161400.ref016" ref-type="bibr">16</xref>].</p></sec></sec><sec id="sec013"><title>Statistical analysis</title><p>Data were analysed using the Statistical Package for the Social Sciences (SPSS 12.1.3 for Windows; SPSS Chicago, IL, USA). For each variable, values are given as mean &#x000b1; SD. Sample size was determined for a desired p value of 0.05 and 80% power to detect a postprandial difference of more than 30% in oxidative stress variables between control and subjects with abdominal obesity. A sample size of a minimum of 10 per group, matched by age, was considered satisfactory because postprandial situation should duplicate the differences expected in the fasting state.</p><p>Due to the sample size and the measurement of variables that do not fulfill the criteria of normality, non-parametric tests were used. The Mann&#x02014;Whitney test was used to assess differences in measured parameters at various time intervals after the OFLT between both groups. The Wilcoxon test was used for comparison of data before and after the OFLT in the same subjects. For the comparison of proportions, Fisher&#x02019;s exact test was used. The degree of relationship between two quantitative variables was analysed by the Spearman correlation coefficient.</p><p>The area under the curve (AUC) was calculated by the trapezoidal rule GraphPad Prism, version 3.0 (GraphPad Software, Inc, San Diego, Calif). Incremental integrated AUC (dAUC) was also calculated after correction for baseline values.</p></sec></sec><sec sec-type="results" id="sec014"><title>Results</title><p>Clinical data and results of biochemical parameters in the fasting state are shown in <xref ref-type="table" rid="pone.0161400.t001">Table 1</xref>. There were no significant differences in age, gender distribution, and fasting glucose values. As expected, fasting insulinemia concentrations and HOMA index were significantly higher in the abdominal obesity group. Fasting GSSG value (0.45&#x000b1; 0.08 vs 0.69&#x000b1; 0.1 U/mg prot, p&#x0003c;0.05), GSSH/GSH ratio (0.25&#x000b1; 0.05 vs 0.6 &#x000b1;0.19%, p&#x0003c;0.01) and MDA level (0.37&#x000b1; 0.06 vs 0.53&#x000b1; 0.12 U/mg prot, p&#x0003c;0.05) were significantly higher in the abdominal obesity group compared to controls (<xref ref-type="table" rid="pone.0161400.t002">Table 2</xref>). These results indicate a higher fasting oxidative stress status in the abdominal obesity group.</p><table-wrap id="pone.0161400.t002" orientation="portrait" position="float"><object-id pub-id-type="doi">10.1371/journal.pone.0161400.t002</object-id><label>Table 2</label><caption><title>Changes in glycemia, HOMA, insulinemia, triglyceridemia and oxidative stress markers during the oral fat load test in the studied groups.</title></caption><alternatives><graphic id="pone.0161400.t002g" xlink:href="pone.0161400.t002"/><table frame="hsides" rules="groups"><colgroup span="1"><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/></colgroup><thead><tr><th align="justify" rowspan="1" colspan="1"/><th align="justify" rowspan="1" colspan="1"/><th align="justify" rowspan="1" colspan="1">Fasting</th><th align="justify" rowspan="1" colspan="1">2h</th><th align="justify" rowspan="1" colspan="1">4h</th><th align="justify" rowspan="1" colspan="1">6h</th><th align="justify" rowspan="1" colspan="1">8h</th></tr></thead><tbody><tr><td align="justify" rowspan="1" colspan="1"><bold>Glucose (mg/dL)</bold></td><td align="justify" rowspan="1" colspan="1"><bold>Control</bold></td><td align="justify" rowspan="1" colspan="1">91.5&#x000b1;8.3</td><td align="justify" rowspan="1" colspan="1">87.1&#x000b1;7.1<xref ref-type="table-fn" rid="t002fn001"><sup>a</sup></xref></td><td align="justify" rowspan="1" colspan="1">86.1&#x000b1;7.8<xref ref-type="table-fn" rid="t002fn001"><sup>a</sup></xref></td><td align="justify" rowspan="1" colspan="1">84.3&#x000b1;5.4<xref ref-type="table-fn" rid="t002fn001"><sup>a</sup></xref></td><td align="justify" rowspan="1" colspan="1">84.1&#x000b1;6.6<xref ref-type="table-fn" rid="t002fn001"><sup>a</sup></xref></td></tr><tr><td align="justify" rowspan="1" colspan="1"/><td align="justify" rowspan="1" colspan="1"><bold>AO</bold></td><td align="justify" rowspan="1" colspan="1">92.8&#x000b1;8.6<xref ref-type="table-fn" rid="t002fn003"><sup>c</sup></xref></td><td align="justify" rowspan="1" colspan="1">92.3&#x000b1;6.7<xref ref-type="table-fn" rid="t002fn003"><sup>c</sup></xref></td><td align="justify" rowspan="1" colspan="1">90.5&#x000b1; 8.5<xref ref-type="table-fn" rid="t002fn003"><sup>c</sup></xref></td><td align="justify" rowspan="1" colspan="1">87.4&#x000b1;7.0<xref ref-type="table-fn" rid="t002fn002"><sup>b</sup></xref></td><td align="justify" rowspan="1" colspan="1">86.7&#x000b1; 5.2<xref ref-type="table-fn" rid="t002fn002"><sup>b</sup></xref></td></tr><tr><td align="justify" rowspan="1" colspan="1"><bold>Insulin (&#x003bc;U/mL)</bold></td><td align="justify" rowspan="1" colspan="1"><bold>Control</bold></td><td align="justify" rowspan="1" colspan="1">5.2&#x000b1;2.7</td><td align="justify" rowspan="1" colspan="1">5.1&#x000b1;2.6</td><td align="justify" rowspan="1" colspan="1">4.4&#x000b1;2.48</td><td align="justify" rowspan="1" colspan="1">3.5&#x000b1;2.8<xref ref-type="table-fn" rid="t002fn001"><sup>a</sup></xref></td><td align="justify" rowspan="1" colspan="1">3.1&#x000b1;1.97<xref ref-type="table-fn" rid="t002fn001"><sup>a</sup></xref></td></tr><tr><td align="justify" rowspan="1" colspan="1"/><td align="justify" rowspan="1" colspan="1"><bold>AO</bold></td><td align="justify" rowspan="1" colspan="1">19.7&#x000b1;14.2<xref ref-type="table-fn" rid="t002fn003"><sup>c</sup></xref></td><td align="justify" rowspan="1" colspan="1">15.9&#x000b1;7.9 8<xref ref-type="table-fn" rid="t002fn003"><sup>c</sup></xref></td><td align="justify" rowspan="1" colspan="1">13.5&#x000b1;9.38<xref ref-type="table-fn" rid="t002fn002"><sup>b</sup></xref><sup>,</sup><xref ref-type="table-fn" rid="t002fn003"><sup>c</sup></xref></td><td align="justify" rowspan="1" colspan="1">9.5&#x000b1;7.28<xref ref-type="table-fn" rid="t002fn002"><sup>b</sup></xref><sup>,</sup><xref ref-type="table-fn" rid="t002fn003"><sup>c</sup></xref></td><td align="justify" rowspan="1" colspan="1">8.2&#x000b1;6.1<xref ref-type="table-fn" rid="t002fn002"><sup>b</sup></xref><sup>,</sup><xref ref-type="table-fn" rid="t002fn003"><sup>c</sup></xref></td></tr><tr><td align="justify" rowspan="1" colspan="1"><bold>HOMA index</bold></td><td align="justify" rowspan="1" colspan="1"><bold>Control</bold></td><td align="justify" rowspan="1" colspan="1">1.1&#x000b1;0.6</td><td align="justify" rowspan="1" colspan="1">1.3&#x000b1;0.7</td><td align="justify" rowspan="1" colspan="1">0.9&#x000b1;0.7</td><td align="justify" rowspan="1" colspan="1">0.7&#x000b1;0.7</td><td align="justify" rowspan="1" colspan="1">0.7&#x000b1;0.6</td></tr><tr><td align="justify" rowspan="1" colspan="1"/><td align="justify" rowspan="1" colspan="1"><bold>AO</bold></td><td align="justify" rowspan="1" colspan="1">4.6&#x000b1;3.9<xref ref-type="table-fn" rid="t002fn003"><sup>c</sup></xref></td><td align="justify" rowspan="1" colspan="1">3.7&#x000b1;1.9<xref ref-type="table-fn" rid="t002fn003"><sup>c</sup></xref></td><td align="justify" rowspan="1" colspan="1">3.2&#x000b1;2.3<xref ref-type="table-fn" rid="t002fn003"><sup>c</sup></xref></td><td align="justify" rowspan="1" colspan="1">2.1&#x000b1;1.8<xref ref-type="table-fn" rid="t002fn002"><sup>b</sup></xref><sup>,</sup><xref ref-type="table-fn" rid="t002fn003"><sup>c</sup></xref></td><td align="justify" rowspan="1" colspan="1">1.7&#x000b1;1.3<xref ref-type="table-fn" rid="t002fn002"><sup>b</sup></xref><sup>,</sup><xref ref-type="table-fn" rid="t002fn003"><sup>c</sup></xref></td></tr><tr><td align="justify" rowspan="1" colspan="1"><bold>C peptide (ng/mL)</bold></td><td align="justify" rowspan="1" colspan="1"><bold>Control</bold></td><td align="justify" rowspan="1" colspan="1">1.8&#x000b1;0.9</td><td align="justify" rowspan="1" colspan="1"/><td align="justify" rowspan="1" colspan="1">1.6&#x000b1;0.9<xref ref-type="table-fn" rid="t002fn001"><sup>a</sup></xref></td><td align="justify" rowspan="1" colspan="1"/><td align="justify" rowspan="1" colspan="1">1.3&#x000b1;0.7<xref ref-type="table-fn" rid="t002fn001"><sup>a</sup></xref></td></tr><tr><td align="justify" rowspan="1" colspan="1"/><td align="justify" rowspan="1" colspan="1"><bold>AO</bold></td><td align="justify" rowspan="1" colspan="1">2.8&#x000b1;1.3<xref ref-type="table-fn" rid="t002fn003"><sup>c</sup></xref></td><td align="justify" rowspan="1" colspan="1"/><td align="justify" rowspan="1" colspan="1">2.5&#x000b1;1.2<xref ref-type="table-fn" rid="t002fn003"><sup>c</sup></xref></td><td align="justify" rowspan="1" colspan="1"/><td align="justify" rowspan="1" colspan="1">2.0&#x000b1;0.9<xref ref-type="table-fn" rid="t002fn002"><sup>b</sup></xref><sup>,</sup><xref ref-type="table-fn" rid="t002fn003"><sup>c</sup></xref></td></tr><tr><td align="justify" rowspan="1" colspan="1"><bold>Triglycerides(mg/dl)</bold></td><td align="justify" rowspan="1" colspan="1"><bold>Control</bold></td><td align="justify" rowspan="1" colspan="1">68.6&#x000b1;21.4</td><td align="justify" rowspan="1" colspan="1">107.9&#x000b1;49.1<xref ref-type="table-fn" rid="t002fn001"><sup>a</sup></xref></td><td align="justify" rowspan="1" colspan="1">122.0&#x000b1;59.4<xref ref-type="table-fn" rid="t002fn001"><sup>a</sup></xref></td><td align="justify" rowspan="1" colspan="1">95.1&#x000b1;66.4<xref ref-type="table-fn" rid="t002fn001"><sup>a</sup></xref></td><td align="justify" rowspan="1" colspan="1">65.6&#x000b1;20.4<xref ref-type="table-fn" rid="t002fn001"><sup>a</sup></xref></td></tr><tr><td align="justify" rowspan="1" colspan="1"/><td align="justify" rowspan="1" colspan="1"><bold>AO</bold></td><td align="justify" rowspan="1" colspan="1">132.8&#x000b1;64.6<xref ref-type="table-fn" rid="t002fn003"><sup>c</sup></xref></td><td align="justify" rowspan="1" colspan="1">178.3&#x000b1;67.9<xref ref-type="table-fn" rid="t002fn002"><sup>b</sup></xref><sup>,</sup><xref ref-type="table-fn" rid="t002fn003"><sup>c</sup></xref></td><td align="justify" rowspan="1" colspan="1">216.0&#x000b1;73.6<xref ref-type="table-fn" rid="t002fn002"><sup>b</sup></xref><sup>,</sup><xref ref-type="table-fn" rid="t002fn003"><sup>c</sup></xref></td><td align="justify" rowspan="1" colspan="1">148.4&#x000b1;49.0<xref ref-type="table-fn" rid="t002fn002"><sup>b</sup></xref><sup>,</sup><xref ref-type="table-fn" rid="t002fn003"><sup>c</sup></xref></td><td align="justify" rowspan="1" colspan="1">111.5&#x000b1;36.4<xref ref-type="table-fn" rid="t002fn002"><sup>b</sup></xref><sup>,</sup><xref ref-type="table-fn" rid="t002fn003"><sup>c</sup></xref></td></tr><tr><td align="justify" rowspan="1" colspan="1"><bold>GSSG (U/mg prot)</bold></td><td align="justify" rowspan="1" colspan="1"><bold>Control</bold></td><td align="justify" rowspan="1" colspan="1">0.45&#x000b1;0.08</td><td align="justify" rowspan="1" colspan="1">0.36&#x000b1;0.07<xref ref-type="table-fn" rid="t002fn001"><sup>a</sup></xref></td><td align="justify" rowspan="1" colspan="1">0.31&#x000b1;0.07<xref ref-type="table-fn" rid="t002fn001"><sup>a</sup></xref></td><td align="justify" rowspan="1" colspan="1">0.28&#x000b1;0.05<xref ref-type="table-fn" rid="t002fn001"><sup>a</sup></xref></td><td align="justify" rowspan="1" colspan="1">0.23&#x000b1;0.05<xref ref-type="table-fn" rid="t002fn001"><sup>a</sup></xref></td></tr><tr><td align="justify" rowspan="1" colspan="1"/><td align="justify" rowspan="1" colspan="1"><bold>AO</bold></td><td align="justify" rowspan="1" colspan="1">0.69&#x000b1;0.1<xref ref-type="table-fn" rid="t002fn003"><sup>c</sup></xref></td><td align="justify" rowspan="1" colspan="1">0.43&#x000b1;0.09<xref ref-type="table-fn" rid="t002fn002"><sup>b</sup></xref><sup>,</sup><xref ref-type="table-fn" rid="t002fn003"><sup>c</sup></xref></td><td align="justify" rowspan="1" colspan="1">0.38&#x000b1;0.08<xref ref-type="table-fn" rid="t002fn002"><sup>b</sup></xref><sup>,</sup><xref ref-type="table-fn" rid="t002fn003"><sup>c</sup></xref></td><td align="justify" rowspan="1" colspan="1">0.33&#x000b1;0.82<xref ref-type="table-fn" rid="t002fn002"><sup>b</sup></xref><sup>,</sup><xref ref-type="table-fn" rid="t002fn003"><sup>c</sup></xref></td><td align="justify" rowspan="1" colspan="1">0.26&#x000b1;0.84<xref ref-type="table-fn" rid="t002fn002"><sup>b</sup></xref></td></tr><tr><td align="justify" rowspan="1" colspan="1"><bold>GSH (U/mg prot)</bold></td><td align="justify" rowspan="1" colspan="1"><bold>Control</bold></td><td align="justify" rowspan="1" colspan="1">20.1&#x000b1;2.3</td><td align="justify" rowspan="1" colspan="1">22.3&#x000b1;1.8<xref ref-type="table-fn" rid="t002fn001"><sup>a</sup></xref></td><td align="justify" rowspan="1" colspan="1">23.3&#x000b1;2.0<xref ref-type="table-fn" rid="t002fn001"><sup>a</sup></xref></td><td align="justify" rowspan="1" colspan="1">24.3&#x000b1;1.7<xref ref-type="table-fn" rid="t002fn001"><sup>a</sup></xref></td><td align="justify" rowspan="1" colspan="1">25.4&#x000b1;1.7<xref ref-type="table-fn" rid="t002fn001"><sup>a</sup></xref></td></tr><tr><td align="justify" rowspan="1" colspan="1"/><td align="justify" rowspan="1" colspan="1"><bold>AO</bold></td><td align="justify" rowspan="1" colspan="1">10.8&#x000b1;3.1</td><td align="justify" rowspan="1" colspan="1">12.5&#x000b1;2.8<xref ref-type="table-fn" rid="t002fn002"><sup>b</sup></xref></td><td align="justify" rowspan="1" colspan="1">14.1&#x000b1;3.0<xref ref-type="table-fn" rid="t002fn002"><sup>b</sup></xref></td><td align="justify" rowspan="1" colspan="1">15.7&#x000b1;3.8<xref ref-type="table-fn" rid="t002fn002"><sup>b</sup></xref></td><td align="justify" rowspan="1" colspan="1">17.1&#x000b1;3.6<xref ref-type="table-fn" rid="t002fn002"><sup>b</sup></xref></td></tr><tr><td align="justify" rowspan="1" colspan="1"><bold>GSSG/GSH x10<sup>1</sup></bold></td><td align="justify" rowspan="1" colspan="1"><bold>Control</bold></td><td align="justify" rowspan="1" colspan="1">0.25&#x000b1;0.05</td><td align="justify" rowspan="1" colspan="1">0.16&#x000b1;0.03<xref ref-type="table-fn" rid="t002fn001"><sup>a</sup></xref></td><td align="justify" rowspan="1" colspan="1">0.13&#x000b1;0.03<xref ref-type="table-fn" rid="t002fn001"><sup>a</sup></xref></td><td align="justify" rowspan="1" colspan="1">0.11&#x000b1;0.02<xref ref-type="table-fn" rid="t002fn001"><sup>a</sup></xref></td><td align="justify" rowspan="1" colspan="1">0.09&#x000b1;0.02<xref ref-type="table-fn" rid="t002fn001"><sup>a</sup></xref></td></tr><tr><td align="justify" rowspan="1" colspan="1"/><td align="justify" rowspan="1" colspan="1"><bold>AO</bold></td><td align="justify" rowspan="1" colspan="1">0.6&#x000b1;0.19<xref ref-type="table-fn" rid="t002fn003"><sup>c</sup></xref></td><td align="justify" rowspan="1" colspan="1">0.35&#x000b1;0.07<xref ref-type="table-fn" rid="t002fn002"><sup>b</sup></xref><sup>,</sup><xref ref-type="table-fn" rid="t002fn003"><sup>c</sup></xref></td><td align="justify" rowspan="1" colspan="1">0.27&#x000b1;0.06<xref ref-type="table-fn" rid="t002fn002"><sup>b</sup></xref><sup>,</sup><xref ref-type="table-fn" rid="t002fn003"><sup>c</sup></xref></td><td align="justify" rowspan="1" colspan="1">0.22&#x000b1;0.49<xref ref-type="table-fn" rid="t002fn002"><sup>b</sup></xref><sup>,</sup><xref ref-type="table-fn" rid="t002fn003"><sup>c</sup></xref></td><td align="justify" rowspan="1" colspan="1">0.15&#x000b1;0.41<xref ref-type="table-fn" rid="t002fn002"><sup>b</sup></xref><sup>,</sup><xref ref-type="table-fn" rid="t002fn003"><sup>c</sup></xref></td></tr><tr><td align="justify" rowspan="1" colspan="1"><bold>MDA (U/mg prot)</bold></td><td align="justify" rowspan="1" colspan="1"><bold>Control</bold></td><td align="justify" rowspan="1" colspan="1">0.37&#x000b1;0.06</td><td align="justify" rowspan="1" colspan="1">0.34&#x000b1;0.03<xref ref-type="table-fn" rid="t002fn001"><sup>a</sup></xref></td><td align="justify" rowspan="1" colspan="1">0.30&#x000b1;0.06<xref ref-type="table-fn" rid="t002fn001"><sup>a</sup></xref></td><td align="justify" rowspan="1" colspan="1">0.22&#x000b1;0.06<xref ref-type="table-fn" rid="t002fn001"><sup>a</sup></xref></td><td align="justify" rowspan="1" colspan="1">0.22&#x000b1;0.06<xref ref-type="table-fn" rid="t002fn001"><sup>a</sup></xref></td></tr><tr><td align="justify" rowspan="1" colspan="1"/><td align="justify" rowspan="1" colspan="1"><bold>AO</bold></td><td align="justify" rowspan="1" colspan="1">0.53&#x000b1;0.12<xref ref-type="table-fn" rid="t002fn003"><sup>c</sup></xref></td><td align="justify" rowspan="1" colspan="1">0.34&#x000b1;0.04<xref ref-type="table-fn" rid="t002fn002"><sup>b</sup></xref></td><td align="justify" rowspan="1" colspan="1">0.24&#x000b1;0.08<xref ref-type="table-fn" rid="t002fn002"><sup>b</sup></xref><sup>,</sup><xref ref-type="table-fn" rid="t002fn003"><sup>c</sup></xref></td><td align="justify" rowspan="1" colspan="1">0.19&#x000b1;0.04<xref ref-type="table-fn" rid="t002fn002"><sup>b</sup></xref><sup>,</sup><xref ref-type="table-fn" rid="t002fn003"><sup>c</sup></xref></td><td align="justify" rowspan="1" colspan="1">0.18&#x000b1;0.02<xref ref-type="table-fn" rid="t002fn002"><sup>b</sup></xref><sup>,</sup><xref ref-type="table-fn" rid="t002fn003"><sup>c</sup></xref></td></tr></tbody></table></alternatives><table-wrap-foot><fn id="t002fn001"><p><sup>a</sup> p&#x0003c; 0,05 fasting vs postprandial in control group.</p></fn><fn id="t002fn002"><p><sup>b</sup> p&#x0003c; 0,01 fasting vs postprandial in AO group.</p></fn><fn id="t002fn003"><p><sup>c</sup> p&#x0003c; 0.01 control vs AO group.</p></fn><fn id="t002fn004"><p>Abbreviations: AO = abdominal obesity;GSH: reduced glutathione;GSSG = oxidizedglutathione; MDA: malonildyaldehide.</p></fn><fn id="t002fn005"><p>C-peptide was analyzed at time 0, 4 and 8 hours.</p></fn></table-wrap-foot></table-wrap><p>Postprandial values of the analyzed parameters are shown in <xref ref-type="table" rid="pone.0161400.t002">Table 2</xref>. During the OFLT we found a significant increase in postprandial triglycerides plasma values achieving the maximum at 4 hours and recovering basal values after 8 hours. However, a significant decrease in glycemia, insulinemia, and c-peptide levels was observed in both groups (<xref ref-type="table" rid="pone.0161400.t002">Table 2</xref>, <xref ref-type="fig" rid="pone.0161400.g001">Fig 1</xref>). The decrease of insulinemia compared to fasting values was significantly higher in the abdominal obesity group compared to the control group. In abdominal obesity group insulinemia at 6 h decreased from 19.7 to 9.5 (50%) and at 8 h to 8.2 (60%). C-peptide levels decreased progressively compared to fasting values, showing significant differences at 4 and 8 h in controls, and at 8 h in subjects with abdominal obesity. We also found that after the OFLT there was a significant decrease in GSSG/GSH ratio at 2, 4, 6 and 8 hours compared to fasting levels in both groups. The MDA value, a byproduct of lipid peroxidation and marker of oxidative stress, also significantly decreased after the OFLT in both groups (<xref ref-type="table" rid="pone.0161400.t002">Table 2</xref>, <xref ref-type="fig" rid="pone.0161400.g001">Fig 1</xref>).</p><fig id="pone.0161400.g001" orientation="portrait" position="float"><object-id pub-id-type="doi">10.1371/journal.pone.0161400.g001</object-id><label>Fig 1</label><caption><title>Plasmatic changes during the oral fat load test in control subjects and subjects with abdominal fat deposits.</title><p>(A) Glycemia during the oral fat load test. (B) Insulinemia during the oral fat load test. (C) GSSG/GSH ratio during the oral fat load test. (a) p &#x0003c; 0.05 fasting vs postprandial in control group. (b) p &#x0003c; 0.01 fasting vs postprandial in Abdominal obesity group. (c) p &#x0003c;0.01 control vs Abdominal obesity group.</p></caption><graphic xlink:href="pone.0161400.g001"/></fig><p>In <xref ref-type="table" rid="pone.0161400.t003">Table 3</xref> are shown the AUC and dAUC. We found significant differences between control and abdominal obesity group.</p><table-wrap id="pone.0161400.t003" orientation="portrait" position="float"><object-id pub-id-type="doi">10.1371/journal.pone.0161400.t003</object-id><label>Table 3</label><caption><title>AUC and dAUCglycemia, insulinemia, triglyceridemia and oxidative stress markers during the oral fat load test.</title></caption><alternatives><graphic id="pone.0161400.t003g" xlink:href="pone.0161400.t003"/><table frame="hsides" rules="groups"><colgroup span="1"><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/></colgroup><thead><tr><th align="justify" rowspan="1" colspan="1"/><th align="justify" rowspan="1" colspan="1">Control group (n = 20)</th><th align="justify" rowspan="1" colspan="1">Abdominal obesity group (n = 20)</th></tr></thead><tbody><tr><td align="justify" rowspan="1" colspan="1"><bold>AUC glucose(mg x dL</bold><sup><bold>-1</bold></sup>
<bold>x h</bold><sup><bold>-1</bold></sup><bold>)</bold></td><td align="justify" rowspan="1" colspan="1">690.6&#x000b1;49.5</td><td align="justify" rowspan="1" colspan="1">720.0&#x000b1;50.57 <xref ref-type="table-fn" rid="t003fn001"><sup>a</sup></xref></td></tr><tr><td align="justify" rowspan="1" colspan="1"><bold>dAUC glucose(mg x dL</bold><sup><bold>-1</bold></sup>
<bold>x h</bold><sup><bold>-1</bold></sup><bold>)</bold></td><td align="justify" rowspan="1" colspan="1">45.3&#x000b1;36.6</td><td align="justify" rowspan="1" colspan="1">44.7&#x000b1;42.3</td></tr><tr><td align="justify" rowspan="1" colspan="1"><bold>AUC insulin(&#x003bc;U x mL</bold><sup><bold>-1</bold></sup>
<bold>x h</bold><sup><bold>-1</bold></sup><bold>)</bold></td><td align="justify" rowspan="1" colspan="1">34.4&#x000b1;16.4</td><td align="justify" rowspan="1" colspan="1">105.7&#x000b1;61.6 <xref ref-type="table-fn" rid="t003fn001"><sup>a</sup></xref></td></tr><tr><td align="justify" rowspan="1" colspan="1"><bold>dAUCinsulin(&#x003bc;U x mL</bold><sup><bold>-1</bold></sup>
<bold>x h</bold><sup><bold>-1</bold></sup><bold>)</bold></td><td align="justify" rowspan="1" colspan="1">15.2&#x000b1;13.2</td><td align="justify" rowspan="1" colspan="1">58.6&#x000b1;64.2 <xref ref-type="table-fn" rid="t003fn001"><sup>a</sup></xref></td></tr><tr><td align="justify" rowspan="1" colspan="1"><bold>AUC HOMA(h</bold><sup><bold>-1</bold></sup><bold>)</bold></td><td align="justify" rowspan="1" colspan="1">10.5&#x000b1;14.9</td><td align="justify" rowspan="1" colspan="1">21.6&#x000b1;10.6 <xref ref-type="table-fn" rid="t003fn001"><sup>a</sup></xref></td></tr><tr><td align="justify" rowspan="1" colspan="1"><bold>dAUC HOMA (h</bold><sup><bold>-1</bold></sup><bold>)</bold></td><td align="justify" rowspan="1" colspan="1">3.7&#x000b1;3.3</td><td align="justify" rowspan="1" colspan="1">14.3&#x000b1;19.8 <xref ref-type="table-fn" rid="t003fn001"><sup>a</sup></xref></td></tr><tr><td align="justify" rowspan="1" colspan="1"><bold>AUC TG(mg x dL</bold><sup><bold>-1</bold></sup>
<bold>x h</bold><sup><bold>-1</bold></sup><bold>)</bold></td><td align="justify" rowspan="1" colspan="1">784.0&#x000b1;330.5</td><td align="justify" rowspan="1" colspan="1">1329.5&#x000b1;438.4 <xref ref-type="table-fn" rid="t003fn001"><sup>a</sup></xref></td></tr><tr><td align="justify" rowspan="1" colspan="1"><bold>dAUC TG(mg x dL</bold><sup><bold>-1</bold></sup>
<bold>x h</bold><sup><bold>-1</bold></sup><bold>)</bold></td><td align="justify" rowspan="1" colspan="1">258.7&#x000b1;192.1</td><td align="justify" rowspan="1" colspan="1">338.9&#x000b1;176.8</td></tr><tr><td align="justify" rowspan="1" colspan="1"><bold>AUC GSSG(U x mg prot</bold><sup><bold>-1</bold></sup>
<bold>x h</bold><sup><bold>-1</bold></sup><bold>)</bold></td><td align="justify" rowspan="1" colspan="1">2.6&#x000b1;0.5</td><td align="justify" rowspan="1" colspan="1">3.3&#x000b1;0.5 <xref ref-type="table-fn" rid="t003fn001"><sup>a</sup></xref></td></tr><tr><td align="justify" rowspan="1" colspan="1"><bold>dAUC GSSG(U x mg prot</bold><sup><bold>-1</bold></sup>
<bold>x h</bold><sup><bold>-1</bold></sup><bold>)</bold></td><td align="justify" rowspan="1" colspan="1">0.96&#x000b1;0.42</td><td align="justify" rowspan="1" colspan="1">2.3&#x000b1;0.6 <xref ref-type="table-fn" rid="t003fn001"><sup>a</sup></xref></td></tr><tr><td align="justify" rowspan="1" colspan="1"><bold>AUC GSH(U x mg prot</bold><sup><bold>-1</bold></sup>
<bold>x h</bold><sup><bold>-1</bold></sup><bold>)</bold></td><td align="justify" rowspan="1" colspan="1">185.1&#x000b1;12.5</td><td align="justify" rowspan="1" colspan="1">112.8&#x000b1;23.4 <xref ref-type="table-fn" rid="t003fn001"><sup>a</sup></xref></td></tr><tr><td align="justify" rowspan="1" colspan="1"><bold>dAUC GSH(U x mg prot</bold><sup><bold>-1</bold></sup>
<bold>x h</bold><sup><bold>-1</bold></sup><bold>)</bold></td><td align="justify" rowspan="1" colspan="1">23.9&#x000b1;18.6</td><td align="justify" rowspan="1" colspan="1">25.9&#x000b1;16.1</td></tr><tr><td align="justify" rowspan="1" colspan="1"><bold>AUC GSSG/GSH (h</bold><sup><bold>-1</bold></sup><bold>)</bold></td><td align="justify" rowspan="1" colspan="1">0.12&#x000b1;0.02</td><td align="justify" rowspan="1" colspan="1">0.25&#x000b1;0.5 <xref ref-type="table-fn" rid="t003fn001"><sup>a</sup></xref></td></tr><tr><td align="justify" rowspan="1" colspan="1"><bold>dAUC GSSG/GSH (h</bold><sup><bold>-1</bold></sup><bold>)</bold></td><td align="justify" rowspan="1" colspan="1">0.06&#x000b1;0.03</td><td align="justify" rowspan="1" colspan="1">0.29&#x000b1;0.12 <xref ref-type="table-fn" rid="t003fn001"><sup>a</sup></xref></td></tr><tr><td align="justify" rowspan="1" colspan="1"><bold>AUC MDA(U x mg prot</bold><sup><bold>-1</bold></sup>
<bold>x h</bold><sup><bold>-1</bold></sup><bold>)</bold></td><td align="justify" rowspan="1" colspan="1">2.4&#x000b1;0.4</td><td align="justify" rowspan="1" colspan="1">2.3&#x000b1;0.3</td></tr><tr><td align="justify" rowspan="1" colspan="1"><bold>dAUC MDA(U x mg prot</bold><sup><bold>-1</bold></sup>
<bold>x h</bold><sup><bold>-1</bold></sup><bold>)</bold></td><td align="justify" rowspan="1" colspan="1">0.69&#x000b1;0.2</td><td align="justify" rowspan="1" colspan="1">1.9&#x000b1;0.8 <xref ref-type="table-fn" rid="t003fn001"><sup>a</sup></xref></td></tr></tbody></table></alternatives><table-wrap-foot><fn id="t003fn001"><p><sup>a</sup> p control vs abdominal obesity group (p&#x0003c;0.01).</p></fn><fn id="t003fn002"><p>Abbreviations: GSH: reduced glutathione; GSSG = oxidized glutathione; MDA: malonildyaldehide.</p></fn></table-wrap-foot></table-wrap><p>Finally, we also evaluated the correlations between two variables (<xref ref-type="table" rid="pone.0161400.t004">Table 4</xref>). Markers of oxidative stress were significantly associated with HOMA, TG, the peak of TG (4 hours) and dAUC of HOMA. The dUAC of TG did not show significant association. Furthermore dAUC of HOMA was correlated with dAUC of GSSG/GSH ratio. However no correlation was found with dAUC of TG.</p><table-wrap id="pone.0161400.t004" orientation="portrait" position="float"><object-id pub-id-type="doi">10.1371/journal.pone.0161400.t004</object-id><label>Table 4</label><caption><title>Correlation coefficients among oxidative stress markers and markers of insulinresistance.</title></caption><alternatives><graphic id="pone.0161400.t004g" xlink:href="pone.0161400.t004"/><table frame="hsides" rules="groups"><colgroup span="1"><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/></colgroup><thead><tr><th align="justify" rowspan="1" colspan="1"/><th align="justify" rowspan="1" colspan="1">GSSG/GSH</th><th align="justify" rowspan="1" colspan="1">dAUC GSSG/GSH (h<sup>-1</sup>)</th><th align="justify" rowspan="1" colspan="1">dAUC HOMA (h<sup>-1</sup>)</th></tr></thead><tbody><tr><td align="justify" rowspan="1" colspan="1"><bold>HOMA index</bold></td><td align="justify" rowspan="1" colspan="1">r 0.659 p&#x0003c;0.001</td><td align="justify" rowspan="1" colspan="1">r 0.646 p&#x0003c;0.001</td><td align="justify" rowspan="1" colspan="1">r 0.756 p&#x0003c;0.001</td></tr><tr><td align="justify" rowspan="1" colspan="1"><bold>TG (mg/dL)</bold></td><td align="justify" rowspan="1" colspan="1">r 0.608 p&#x0003c;0.001</td><td align="justify" rowspan="1" colspan="1">r 0.610 p&#x0003c;0.001</td><td align="justify" rowspan="1" colspan="1">r 0.611 p&#x0003c;0.001</td></tr><tr><td align="justify" rowspan="1" colspan="1"><bold>Peak of TG (mg/dL; 4 h)</bold></td><td align="justify" rowspan="1" colspan="1">r 0.454 p 0.003</td><td align="justify" rowspan="1" colspan="1">r 0.423 p 0.006</td><td align="justify" rowspan="1" colspan="1">r 0.537 p&#x0003c;0.001</td></tr><tr><td align="justify" rowspan="1" colspan="1"><bold>GSSG (U/mg prot)</bold></td><td align="justify" rowspan="1" colspan="1">r 0.858 p&#x0003c;0.001</td><td align="justify" rowspan="1" colspan="1">r 0.819 p&#x0003c;0.001</td><td align="justify" rowspan="1" colspan="1">r 0.442 p 0.004</td></tr><tr><td align="justify" rowspan="1" colspan="1"><bold>GSH (U/mg prot)</bold></td><td align="justify" rowspan="1" colspan="1">r -0.924 p&#x0003c;0.001</td><td align="justify" rowspan="1" colspan="1">r -0.929 p&#x0003c;0.001</td><td align="justify" rowspan="1" colspan="1">r -0.444 p 0.004</td></tr><tr><td align="justify" rowspan="1" colspan="1"><bold>GSSG/GSH</bold></td><td align="justify" rowspan="1" colspan="1"/><td align="justify" rowspan="1" colspan="1">r 0.977 p&#x0003c;0.001</td><td align="justify" rowspan="1" colspan="1">r 0.471 p0.002</td></tr><tr><td align="justify" rowspan="1" colspan="1"><bold>MDA (U/mg prot)</bold></td><td align="justify" rowspan="1" colspan="1">r 0.577 p&#x0003c;0.001</td><td align="justify" rowspan="1" colspan="1">r 0.492 p&#x0003c;0.001</td><td align="justify" rowspan="1" colspan="1">r 0.287 p0.073</td></tr><tr><td align="justify" rowspan="1" colspan="1"><bold>dAUC glucose (mg x dL</bold><sup><bold>-1</bold></sup>
<bold>x h</bold><sup><bold>-1</bold></sup><bold>)</bold></td><td align="justify" rowspan="1" colspan="1">r 0.011 p0.946</td><td align="justify" rowspan="1" colspan="1">r 0.008 p0.961</td><td align="justify" rowspan="1" colspan="1">r 0.014 p0.932</td></tr><tr><td align="justify" rowspan="1" colspan="1"><bold>dAUC insulin (&#x003bc;U x mL</bold><sup><bold>-1</bold></sup>
<bold>x h</bold><sup><bold>-1</bold></sup><bold>)</bold></td><td align="justify" rowspan="1" colspan="1">r 0.557 p&#x0003c;0.001</td><td align="justify" rowspan="1" colspan="1">r 0.567 p&#x0003c;0.001</td><td align="justify" rowspan="1" colspan="1">r 0.871 p&#x0003c;0.001</td></tr><tr><td align="justify" rowspan="1" colspan="1"><bold>dAUC HOMA (h</bold><sup><bold>-1</bold></sup><bold>)</bold></td><td align="justify" rowspan="1" colspan="1">r 0.471 p0.002</td><td align="justify" rowspan="1" colspan="1">r 0.470 p0.002</td><td align="justify" rowspan="1" colspan="1"/></tr><tr><td align="justify" rowspan="1" colspan="1"><bold>dAUC TG (mg x dL</bold><sup><bold>-1</bold></sup>
<bold>x h</bold><sup><bold>-1</bold></sup><bold>)</bold></td><td align="justify" rowspan="1" colspan="1">r 0.134 p0.409</td><td align="justify" rowspan="1" colspan="1">r 0.093 p0.570</td><td align="justify" rowspan="1" colspan="1">r 0.292 p0.068</td></tr><tr><td align="justify" rowspan="1" colspan="1"><bold>dAUC GSSG/GSH (h</bold><sup><bold>-1</bold></sup><bold>)</bold></td><td align="justify" rowspan="1" colspan="1">r 0.977 p&#x0003c;0.001</td><td align="justify" rowspan="1" colspan="1"/><td align="justify" rowspan="1" colspan="1">r 0.470 p0.002</td></tr></tbody></table></alternatives><table-wrap-foot><fn id="t004fn001"><p>Abbreviations:GSH: reduced glutathione; GSSG = oxidized glutathione; MDA: malonildyaldehide; TG = triglycerides.</p></fn></table-wrap-foot></table-wrap></sec><sec sec-type="conclusions" id="sec015"><title>Discussion</title><p>In our study, non diabetic subjects with abdominal obesity had fasting HOMA index values fourth fold higher than controls, higher fasting triglyceridemia and higher fasting oxidative stress markers. Moreover, significantly higher postprandial triglyceridemia was observed after an OLFT. As expected, these results indicate that abdominal obesity can be considered as a model of fasting IR and altered PL.</p><p>We have found that during the OFLT, glucose and insulin values significantly decreased in abdominal obesity and control groups with a higher decrease in abdominal obesity subjects (50% at 6 h and 60% at 8 h in the abdominal obesity group). We also found that c-peptide levels decreased in both groups (approximately 10% at 4 h and 30% at 8 h in both groups). Previous studies have shown that the intake of sugars, especially fructose, has been associated with IR in rats [<xref rid="pone.0161400.ref017" ref-type="bibr">17</xref>]. In contrast to our results, hyperlipidemia generated by intravenous infusion of lipids consistently induces acute insulin resistance. However, when hyperlipidemia is eliminated, glucose tolerance returns to the normal range [<xref rid="pone.0161400.ref018" ref-type="bibr">18</xref>].</p><p>Many mechanisms have been implicated in the induction of insulin resistance in the postprandial state. In human models of insulin resistance such as subjects with abdominal obesity, metabolic syndrome, obesity and type 2 diabetes, the increased oxidation of energetic substrates generated by excessive postprandial TG or FFA can activate various serine kinases that negatively affect insulin action inducing IR [<xref rid="pone.0161400.ref019" ref-type="bibr">19</xref>,<xref rid="pone.0161400.ref020" ref-type="bibr">20</xref>]. Furthermore, an excess of postprandial FFA disposal induces a metabolic shift toward increased reliance on fat relative to glucose for energy production. Experimentally, this shift increases mitochondrial H2O2 production as has been shown in skeletal muscle, adipose tissue, and kidney of mice fed with a high-fat diet [<xref rid="pone.0161400.ref021" ref-type="bibr">21</xref>&#x02013;<xref rid="pone.0161400.ref023" ref-type="bibr">23</xref>]. In contrast, the suppression of beta-oxidation or selective scavenging of mitochondrial H2O2 preserves skeletal muscle insulin sensitivity in models of diet-induced obesity [<xref rid="pone.0161400.ref020" ref-type="bibr">20</xref>,<xref rid="pone.0161400.ref024" ref-type="bibr">24</xref>].</p><p>In addition, insulin resistance states show fasting and postprandial increase of oxidative stress markers. In fact, oxidative stress has been implicated in the development of insulin resistance [<xref rid="pone.0161400.ref025" ref-type="bibr">25</xref>]. We have found that fasting oxidative stress markers are significantly increased in abdominal obesity subjects compared to controls and are significantly related to anthropometric and biochemical markers of IR. Mechanisms by which high dietary fat and obesity induce overproduction of ROS include infiltration of macrophages into adipose tissue, release of proinflammatory adipokines, elevated expression of NADPH oxidase (Nox), and enhanced generation of oxidative stress by mitochondria [<xref rid="pone.0161400.ref026" ref-type="bibr">26</xref>,<xref rid="pone.0161400.ref027" ref-type="bibr">27</xref>]. In this line, increased levels of lipid peroxidation products and markers of oxidized DNA have been found in plasma, skeletal muscle and urine from obese individuals [<xref rid="pone.0161400.ref028" ref-type="bibr">28</xref>]. More recently, elevated levels of oxidized proteins have been observed in subcutaneous adipose tissue [<xref rid="pone.0161400.ref029" ref-type="bibr">29</xref>,<xref rid="pone.0161400.ref030" ref-type="bibr">30</xref>].</p><p>In contrast to previous discussion, our study has demonstrated a significant reduction of postprandial glycemia, insulinemia, c-peptide and oxidative stress markers using an acute oral overload of unsaturated fat. We have found a significant correlation between oxidative stress markers and postprandial lipemia. There is an increase of TG achieving the maximum peak four hours after the beginning of the test. However, although postprandial lipemia has been implicated in the development of insulin resistance and oxidative stress, and despite the increase of TG, there are significant reductions of the HOMA index and oxidative stress markers.</p><p>The influence of dietary macronutrients in insulin sensitivity is not well known. Previous evidence suggests that dietary fat might also impact on insulin sensitivity in humans. Experimental and interventional studies using saturated fat have demonstrated an increase in fasting and postprandial IR [<xref rid="pone.0161400.ref031" ref-type="bibr">31</xref>&#x02013;<xref rid="pone.0161400.ref034" ref-type="bibr">34</xref>]. In addition, a high membrane content of phospholipids rich in saturated fat can alter phyco-chemical properties decreasing the recruitment of GLUT. In contrast, a more fluid membrane with unsaturated fat can improve insulin sensitivity [<xref rid="pone.0161400.ref035" ref-type="bibr">35</xref>]. Iggman et al demonstrated in elderly men that palmitic acid, the major saturated fatty acid found in adipose tissue, inversely correlates to insulin sensitivity measured by euglucemic-hyperinsulinemic clamp. However, they also found a positive relation of insulin sensitivity with the content of linoleic acid in adipose tissue [<xref rid="pone.0161400.ref036" ref-type="bibr">36</xref>]. It is in accordance with our results because our commercial liquid preparation of high-fat meal of long chain triglycerides is composed in the majority by linoleic acid (59%). Furthermore, in line with our findings, the replacements of dietary saturated fat by unsaturated fat also improved fasting insulin sensitivity [<xref rid="pone.0161400.ref037" ref-type="bibr">37</xref>]. Several other studies have demonstrated that unsaturated fat improves fasting and postprandial IR, although the mechanism is largely unknown [<xref rid="pone.0161400.ref038" ref-type="bibr">38</xref>]. Moreover the PREDIMED study has recently demonstrated that unsaturated fat can improve fasting insulin sensitivity and prevent the incidence of type 2 diabetes [<xref rid="pone.0161400.ref039" ref-type="bibr">39</xref>].</p><p>In the same line, the type of fat can also regulate oxidative stress status [<xref rid="pone.0161400.ref009" ref-type="bibr">9</xref>]. Unsaturated fat has shown beneficial effects [<xref rid="pone.0161400.ref010" ref-type="bibr">10</xref>,<xref rid="pone.0161400.ref011" ref-type="bibr">11</xref>]. We have found a significant reduction in oxidative stress markers throughout the fat load test. Finally, a postprandial reduction in oxidative stress markers can improve insulin sensitivity, as observed in our study and others [<xref rid="pone.0161400.ref024" ref-type="bibr">24</xref>,<xref rid="pone.0161400.ref040" ref-type="bibr">40</xref>,<xref rid="pone.0161400.ref041" ref-type="bibr">41</xref>]. In fact, the decrease of HOMA significantly correlated to postprandial decreases of oxidative stress markers and insulin, but not glucose. Furthermore dAUC GSSG/GSH only correlated significantly with dAUC HOMA and dAUC insulin. There was no significant association with dAUC glucose. It is in accordance with the findings of Delarue et al who found that after a dietary substitution of dietary fat by unsaturated fat, oral glucose load induced a significant decrease in insulinemic response without alteration of the glucose response [<xref rid="pone.0161400.ref042" ref-type="bibr">42</xref>].</p><p>Our study has some limitations. The OFLT is an acute intervention thus we cannot extrapolate long term beneficial effects of unsaturated fat on postprandial glycemia, insulinemia and oxidative stress status. In the same line, the use of a test with commercial liquid preparation of fat is a non physiological ingestion of fat. Furthermore, since OFLT was not associated with an oral glucose load it is not possible assess in depth insulin resistance and stimulated insulin secretion after oral fat load. We have not measured the metabolic parameters (glucose, insulin and oxidative stress markers) some hours later of the OFLT to assess that the reduction in this parameters was dependent of the prolonged fasting state. Finally, oxidative stress markers analyzed could be also altered by others players regulating the postprandial state.</p><p>In summary, after an OFLT using predominantly unsaturated fat, glycemia, insulinemia and oxidative stress markers significantly decreased in healthy lean subjects and nondiabetic abdominal obesity subjects. The exact mechanism to explain these results is unknown. We speculate that the use of unsaturated fat and the significant decrease of postprandial oxidative stress markers observed can be responsible, among several other mechanisms, of the postprandial glycemia and insulinemia decrease. However, more studies are necessary to confirm the postprandial beneficial effect on glucose and insulin plasma values observed using unsaturated fat.</p></sec><sec sec-type="supplementary-material" id="sec016"><title>Supporting Information</title><supplementary-material content-type="local-data" id="pone.0161400.s001"><label>S1 File</label><caption><title>Data used for the analysis.</title><p>(SAV)</p></caption><media xlink:href="pone.0161400.s001.sav"><caption><p>Click here for additional data file.</p></caption></media></supplementary-material></sec></body><back><ref-list><title>References</title><ref id="pone.0161400.ref001"><label>1</label><mixed-citation publication-type="journal"><name><surname>Ogden</surname><given-names>CL</given-names></name>, <name><surname>Carroll</surname><given-names>MD</given-names></name>, <name><surname>Curtin</surname><given-names>LR</given-names></name>, <name><surname>McDowell</surname><given-names>MA</given-names></name>, <name><surname>Tabak</surname><given-names>CJ</given-names></name>, <name><surname>Flegal</surname><given-names>KM</given-names></name>. <article-title>Prevalence of overweight and obesity in the United States, 1999&#x02013;2004</article-title>. <source>JAMA</source>. <year>2006</year>;<volume>295</volume>:<fpage>1549</fpage>&#x02013;<lpage>55</lpage>. <pub-id pub-id-type="pmid">16595758</pub-id></mixed-citation></ref><ref id="pone.0161400.ref002"><label>2</label><mixed-citation publication-type="journal"><name><surname>Capurso</surname><given-names>C</given-names></name>, <name><surname>Capurso</surname><given-names>A</given-names></name>. <article-title>From excess adiposity to insulin resistance: the role of free fatty acids</article-title>. <source>Vascul Pharmacol</source>. <year>2012</year>;<volume>57</volume>:<fpage>91</fpage>&#x02013;<lpage>7</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1016/j.vph.2012.05.003">10.1016/j.vph.2012.05.003</ext-link></comment>
<pub-id pub-id-type="pmid">22609131</pub-id></mixed-citation></ref><ref id="pone.0161400.ref003"><label>3</label><mixed-citation publication-type="journal"><name><surname>Eckel</surname><given-names>RH</given-names></name>. <article-title>Obesity</article-title>. <source>Circulation</source>. <year>2005</year>;<volume>111</volume>:<fpage>e257</fpage>&#x02013;<lpage>9</lpage>. <pub-id pub-id-type="pmid">15837935</pub-id></mixed-citation></ref><ref id="pone.0161400.ref004"><label>4</label><mixed-citation publication-type="journal"><name><surname>Fernandez-Sanchez</surname><given-names>A</given-names></name>, <name><surname>Madrigal-Santillan</surname><given-names>E</given-names></name>, <name><surname>Bautista</surname><given-names>M</given-names></name>, <name><surname>Esquivel-Soto</surname><given-names>J</given-names></name>, <name><surname>Morales-Gonzalez</surname><given-names>A</given-names></name>, <name><surname>Esquivel-Chirino</surname><given-names>C</given-names></name>
<etal>et al</etal>
<article-title>Inflammation, oxidative stress, and obesity</article-title>. <source>Int J Mol Sci</source>. <year>2011</year>;<volume>12</volume>:<fpage>3117</fpage>&#x02013;<lpage>32</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.3390/ijms12053117">10.3390/ijms12053117</ext-link></comment>
<pub-id pub-id-type="pmid">21686173</pub-id></mixed-citation></ref><ref id="pone.0161400.ref005"><label>5</label><mixed-citation publication-type="journal"><name><surname>Wassmann</surname><given-names>S</given-names></name>, <name><surname>Wassmann</surname><given-names>K</given-names></name>, <name><surname>Nickenig</surname><given-names>G</given-names></name>. <article-title>Modulation of oxidant and antioxidant enzyme expression and function in vascular cells</article-title>. <source>Hypertension</source>. <year>2004</year>;<volume>44</volume>:<fpage>381</fpage>&#x02013;<lpage>6</lpage>. <pub-id pub-id-type="pmid">15337734</pub-id></mixed-citation></ref><ref id="pone.0161400.ref006"><label>6</label><mixed-citation publication-type="journal"><name><surname>Stocker</surname><given-names>R</given-names></name>, <name><surname>Keaney</surname><given-names>JF</given-names><suffix>Jr</suffix></name>. <article-title>Role of oxidative modifications in atherosclerosis</article-title>. <source>Physiol Rev</source>. <year>2004</year>;<volume>84</volume>:<fpage>1381</fpage>&#x02013;<lpage>478</lpage>. <pub-id pub-id-type="pmid">15383655</pub-id></mixed-citation></ref><ref id="pone.0161400.ref007"><label>7</label><mixed-citation publication-type="journal"><name><surname>Paglialunga</surname><given-names>S</given-names></name>, <name><surname>Cianflone</surname><given-names>K</given-names></name>. <article-title>Regulation of postprandial lipemia: an update on current trends</article-title>. <source>Appl Physiol Nutr Metab</source>. <year>2007</year>;<volume>32</volume>:<fpage>61</fpage>&#x02013;<lpage>75</lpage>. <pub-id pub-id-type="pmid">17332785</pub-id></mixed-citation></ref><ref id="pone.0161400.ref008"><label>8</label><mixed-citation publication-type="journal"><name><surname>Castro Cabezas</surname><given-names>M</given-names></name>, <name><surname>de Bruin</surname><given-names>TW</given-names></name>, <name><surname>de Valk</surname><given-names>HW</given-names></name>, <name><surname>Shoulders</surname><given-names>CC</given-names></name>, <name><surname>Jansen</surname><given-names>H</given-names></name>, <name><surname>Willem Erkelens</surname><given-names>D</given-names></name>. <article-title>Impaired fatty acidmetabolism in familial combined hyperlipidemia. A mechanism associating hepatic apolipoprotein B overproduction and insulin resistance</article-title>. <source>J Clin Invest</source>. <year>1993</year>;<volume>92</volume>:<fpage>160</fpage>&#x02013;<lpage>8</lpage>. <pub-id pub-id-type="pmid">8100834</pub-id></mixed-citation></ref><ref id="pone.0161400.ref009"><label>9</label><mixed-citation publication-type="journal"><name><surname>Tsai</surname><given-names>WC</given-names></name>, <name><surname>Li</surname><given-names>YH</given-names></name>, <name><surname>Lin</surname><given-names>CC</given-names></name>, <name><surname>Chao</surname><given-names>TH</given-names></name>, <name><surname>Chen</surname><given-names>JH</given-names></name>. <article-title>Effects of oxidative stress on endothelialfunction after a high-fat meal</article-title>. <source>Clin Sci (Lond)</source>. <year>2004</year>;<volume>106</volume>:<fpage>315</fpage>&#x02013;<lpage>9</lpage>.<pub-id pub-id-type="pmid">14561213</pub-id></mixed-citation></ref><ref id="pone.0161400.ref010"><label>10</label><mixed-citation publication-type="journal"><name><surname>Cortes</surname><given-names>B</given-names></name>, <name><surname>Nunez</surname><given-names>I</given-names></name>, <name><surname>Cofan</surname><given-names>M</given-names></name>, <name><surname>Gilabert</surname><given-names>R</given-names></name>, <name><surname>Perez-Heras</surname><given-names>A</given-names></name>, <name><surname>Casals</surname><given-names>E</given-names></name>
<etal>et al</etal>
<article-title>Acute effects of high-fat meals enrichedwith walnuts or olive oil on postprandial endothelial function</article-title>. <source>J Am Coll Cardiol</source>. <year>2006</year>;<volume>48</volume>:<fpage>1666</fpage>&#x02013;<lpage>71</lpage>. <pub-id pub-id-type="pmid">17045905</pub-id></mixed-citation></ref><ref id="pone.0161400.ref011"><label>11</label><mixed-citation publication-type="journal"><name><surname>Weinbrenner</surname><given-names>T</given-names></name>, <name><surname>Fito</surname><given-names>M</given-names></name>, <name><surname>de la Torre</surname><given-names>R</given-names></name>, <name><surname>Saez</surname><given-names>GT</given-names></name>, <name><surname>Rijken</surname><given-names>P</given-names></name>, <name><surname>Tormos</surname><given-names>C</given-names></name>
<etal>et al</etal>
<article-title>Olive oils high in phenolic compounds modulate oxidative/antioxidative status in men</article-title>. <source>J Nutr</source>. <year>2004</year>;<volume>134</volume>:<fpage>2314</fpage>&#x02013;<lpage>21</lpage>. <pub-id pub-id-type="pmid">15333722</pub-id></mixed-citation></ref><ref id="pone.0161400.ref012"><label>12</label><mixed-citation publication-type="journal"><name><surname>Lozano</surname><given-names>A</given-names></name>, <name><surname>Perez-Martinez</surname><given-names>P</given-names></name>, <name><surname>Marin</surname><given-names>C</given-names></name>, <name><surname>Tinahones</surname><given-names>FJ</given-names></name>, <name><surname>Delgado-Lista</surname><given-names>J</given-names></name>, <name><surname>Cruz-Teno</surname><given-names>C</given-names></name>
<etal>et al</etal>
<article-title>An acute intake of a walnut enriched meal improves postprandial adiponectin response in healthyyoung adults</article-title>. <source>Nutr Res</source>. <year>2013</year>;<volume>33</volume>:<fpage>1012</fpage>&#x02013;<lpage>8</lpage>. <pub-id pub-id-type="pmid">24267040</pub-id></mixed-citation></ref><ref id="pone.0161400.ref013"><label>13</label><mixed-citation publication-type="journal"><name><surname>Matthews</surname><given-names>DR</given-names></name>, <name><surname>Hosker</surname><given-names>JP</given-names></name>, <name><surname>Rudenski</surname><given-names>AS</given-names></name>, <name><surname>Naylor</surname><given-names>BA</given-names></name>, <name><surname>Treacher</surname><given-names>DF</given-names></name>, <name><surname>Turner</surname><given-names>RC</given-names></name>. <article-title>Homeostasis modelassessment: insulin resistance and beta-cell function from fasting plasmaglucose and insulin concentrations in man</article-title>. <source>Diabetologia</source>. <year>1985</year>;<volume>28</volume>:<fpage>412</fpage>&#x02013;<lpage>9</lpage>. <pub-id pub-id-type="pmid">3899825</pub-id></mixed-citation></ref><ref id="pone.0161400.ref014"><label>14</label><mixed-citation publication-type="journal"><name><surname>Pedro</surname><given-names>T</given-names></name>, <name><surname>Martinez-Hervas</surname><given-names>S</given-names></name>, <name><surname>Tormo</surname><given-names>C</given-names></name>, <name><surname>Garcia-Garcia</surname><given-names>AB</given-names></name>, <name><surname>Saez-Tormo</surname><given-names>G</given-names></name>, <name><surname>Ascaso</surname><given-names>JF</given-names></name>
<etal>et al</etal>
<article-title>Oxidative stress andantioxidant enzyme values in lymphomonocytes after an oral unsaturatedfat load test in familial hypercholesterolemic subjects</article-title>. <source>Transl Res</source>. <year>2013</year>;<volume>161</volume>:<fpage>50</fpage>&#x02013;<lpage>6</lpage>. <pub-id pub-id-type="pmid">23072926</pub-id></mixed-citation></ref><ref id="pone.0161400.ref015"><label>15</label><mixed-citation publication-type="journal"><name><surname>Navarro</surname><given-names>J</given-names></name>, <name><surname>Obrador</surname><given-names>E</given-names></name>, <name><surname>Pellicer</surname><given-names>JA</given-names></name>, <name><surname>Aseni</surname><given-names>M</given-names></name>, <name><surname>Vi&#x000f1;a</surname><given-names>J</given-names></name>, <name><surname>Estrela</surname><given-names>JM</given-names></name>. <article-title>Blood glutathione as an index of radiation-induced oxidative stress in mice and humans</article-title>. <source>Free Radic Biol Med</source>. <year>1997</year>;<volume>22</volume>:<fpage>1203</fpage>&#x02013;<lpage>9</lpage>. <pub-id pub-id-type="pmid">9098094</pub-id></mixed-citation></ref><ref id="pone.0161400.ref016"><label>16</label><mixed-citation publication-type="journal"><name><surname>Oltra</surname><given-names>AM</given-names></name>, <name><surname>Carbonell</surname><given-names>F</given-names></name>, <name><surname>Tormos</surname><given-names>C</given-names></name>, <name><surname>Iradi</surname><given-names>A</given-names></name>, <name><surname>Saez</surname><given-names>GT</given-names></name>. <article-title>Antioxidant enzyme activities andthe production of MDA and 8-oxo-dG in chronic lymphocytic leukemia</article-title>. <source>Free Radic Biol Med</source>. <year>2001</year>;<volume>30</volume>:<fpage>1286</fpage>&#x02013;<lpage>92</lpage>. <pub-id pub-id-type="pmid">11368926</pub-id></mixed-citation></ref><ref id="pone.0161400.ref017"><label>17</label><mixed-citation publication-type="journal"><name><surname>Le</surname><given-names>KA</given-names></name>, <name><surname>Tappy</surname><given-names>L</given-names></name>. <article-title>Metabolic effects of fructose</article-title>. <source>Curr Opin Clin Nutr Metab Care</source>. <year>2006</year>;<volume>9</volume>:<fpage>469</fpage>&#x02013;<lpage>75</lpage>. <pub-id pub-id-type="pmid">16778579</pub-id></mixed-citation></ref><ref id="pone.0161400.ref018"><label>18</label><mixed-citation publication-type="journal"><name><surname>Belfort</surname><given-names>R</given-names></name>, <name><surname>Mandarino</surname><given-names>L</given-names></name>, <name><surname>Kashyap</surname><given-names>S</given-names></name>, <name><surname>Wirfel</surname><given-names>K</given-names></name>, <name><surname>Pratipanawatr</surname><given-names>T</given-names></name>, <name><surname>Berria</surname><given-names>R</given-names></name>
<etal>et al</etal>
<article-title>Dose-response effect of elevatedplasma free fatty acid on insulin signaling</article-title>. <source>Diabetes</source>. <year>2005</year>;<volume>54</volume>:<fpage>1640</fpage>&#x02013;<lpage>8</lpage>. <pub-id pub-id-type="pmid">15919784</pub-id></mixed-citation></ref><ref id="pone.0161400.ref019"><label>19</label><mixed-citation publication-type="journal"><name><surname>Berlett</surname><given-names>BS</given-names></name>, <name><surname>Stadtman</surname><given-names>ER</given-names></name>. <article-title>Protein oxidation in aging, disease, and oxidative stress</article-title>. <source>J Biol Chem</source>. <year>1997</year>:<volume>272</volume>:<fpage>20313</fpage>&#x02013;<lpage>6</lpage>. <pub-id pub-id-type="pmid">9252331</pub-id></mixed-citation></ref><ref id="pone.0161400.ref020"><label>20</label><mixed-citation publication-type="journal"><name><surname>Koves</surname><given-names>TR</given-names></name>, <name><surname>Ussher</surname><given-names>JR</given-names></name>, <name><surname>Noland</surname><given-names>RC</given-names></name>, <name><surname>Slentz</surname><given-names>D</given-names></name>, <name><surname>Mosedale</surname><given-names>M</given-names></name>, <name><surname>Ikayeva</surname><given-names>O</given-names></name>
<etal>et al</etal>
<article-title>Mitochondrial overload andincomplete fatty acid oxidation contribute to skeletal muscle insulinresistance</article-title>. <source>Cell Metab</source>. <year>2008</year>;<volume>7</volume>:<fpage>45</fpage>&#x02013;<lpage>56</lpage>. <pub-id pub-id-type="pmid">18177724</pub-id></mixed-citation></ref><ref id="pone.0161400.ref021"><label>21</label><mixed-citation publication-type="journal"><name><surname>Anderson</surname><given-names>EJ</given-names></name>, <name><surname>Lustig</surname><given-names>ME</given-names></name>, <name><surname>Boyle</surname><given-names>KE</given-names></name>, <name><surname>Woodlief</surname><given-names>TL</given-names></name>, <name><surname>Kane</surname><given-names>DA</given-names></name>, <name><surname>Lin</surname><given-names>CT</given-names></name>
<etal>et al</etal>
<article-title>Mitochondrial H2O2 emissionand cellular redox state link excess fat intake to insulin resistance in bothrodents and humans</article-title>. <source>J Clin Invest</source>. <year>2009</year>;<volume>119</volume>:<fpage>573</fpage>&#x02013;<lpage>81</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1172/JCI37048">10.1172/JCI37048</ext-link></comment>
<pub-id pub-id-type="pmid">19188683</pub-id></mixed-citation></ref><ref id="pone.0161400.ref022"><label>22</label><mixed-citation publication-type="journal"><name><surname>Curtis</surname><given-names>JM</given-names></name>, <name><surname>Grimsrud</surname><given-names>PA</given-names></name>, <name><surname>Wright</surname><given-names>WS</given-names></name>, <name><surname>Xu</surname><given-names>X</given-names></name>, <name><surname>Foncea</surname><given-names>RE</given-names></name>, <name><surname>Graham</surname><given-names>DW</given-names></name>
<etal>et al</etal>
<article-title>Downregulation of adipose glutathione S-transferase A4 leads to increased protein carbonylation,oxidative stress, and mitochondrial dysfunction</article-title>. <source>Diabetes</source>. <year>2010</year>;<volume>59</volume>:<fpage>1132</fpage>&#x02013;<lpage>42</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.2337/db09-1105">10.2337/db09-1105</ext-link></comment>
<pub-id pub-id-type="pmid">20150287</pub-id></mixed-citation></ref><ref id="pone.0161400.ref023"><label>23</label><mixed-citation publication-type="journal"><name><surname>Ruggiero</surname><given-names>C</given-names></name>, <name><surname>Ehrenshaft</surname><given-names>M</given-names></name>, <name><surname>Cleland</surname><given-names>E</given-names></name>, <name><surname>Stadler</surname><given-names>K</given-names></name>. <article-title>High-fat diet induces aninitial adaptation of mitochondrial bioenergetics in the kidney despiteevident oxidative stress and mitochondrial ROS production</article-title>. <source>Am J Physiol Endocrinol Metab</source>. <year>2011</year>;<volume>300</volume>:<fpage>E1047</fpage>&#x02013;<lpage>58</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1152/ajpendo.00666.2010">10.1152/ajpendo.00666.2010</ext-link></comment>
<pub-id pub-id-type="pmid">21386058</pub-id></mixed-citation></ref><ref id="pone.0161400.ref024"><label>24</label><mixed-citation publication-type="journal"><name><surname>Chen</surname><given-names>L</given-names></name>, <name><surname>Na</surname><given-names>R</given-names></name>, <name><surname>Gu</surname><given-names>M</given-names></name>, <name><surname>Salmon</surname><given-names>AB</given-names></name>, <name><surname>Liu</surname><given-names>Y</given-names></name>, <name><surname>Liang</surname><given-names>H</given-names></name>
<etal>et al</etal>
<article-title>Reduction of mitochondrial H2O2 by overexpressing peroxiredoxin 3 improves glucose tolerance in mice</article-title>. <source>Aging Cell</source>. <year>2008</year>;<volume>7</volume>:<fpage>866</fpage>&#x02013;<lpage>78</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1111/j.1474-9726.2008.00432.x">10.1111/j.1474-9726.2008.00432.x</ext-link></comment>
<pub-id pub-id-type="pmid">18778410</pub-id></mixed-citation></ref><ref id="pone.0161400.ref025"><label>25</label><mixed-citation publication-type="journal"><name><surname>Ceriello</surname><given-names>A</given-names></name>, <name><surname>Motz</surname><given-names>E</given-names></name>. <article-title>Is oxidative stress the pathogenic mechanismunderlying insulin resistance, diabetes, and cardiovascular disease? Thecommon soil hypothesis revisited</article-title>. <source>Arterioscler Thromb Vasc Biol</source>. <year>2004</year>;<volume>24</volume>;<fpage>816</fpage>&#x02013;<lpage>23</lpage>. <pub-id pub-id-type="pmid">14976002</pub-id></mixed-citation></ref><ref id="pone.0161400.ref026"><label>26</label><mixed-citation publication-type="journal"><name><surname>Fisher-Wellman</surname><given-names>KH</given-names></name>, <name><surname>Neufer</surname><given-names>PD</given-names></name>. <article-title>Linking mitochondrial bioenergetics to insulin resistance via redox biology</article-title>. <source>Trends Endocrinol Metab</source>. <year>2012</year>;<volume>23</volume>:<fpage>142</fpage>&#x02013;<lpage>53</lpage>.<pub-id pub-id-type="pmid">22305519</pub-id></mixed-citation></ref><ref id="pone.0161400.ref027"><label>27</label><mixed-citation publication-type="journal"><name><surname>Olefsky</surname><given-names>JM</given-names></name>, <name><surname>Glass</surname><given-names>CK</given-names></name>. <article-title>Macrophages, inflammation, and insulin resistance</article-title>. <source>Annu Rev Physiol</source>. <year>2010</year>;<volume>72</volume>:<fpage>219</fpage>&#x02013;<lpage>46</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1146/annurev-physiol-021909-135846">10.1146/annurev-physiol-021909-135846</ext-link></comment>
<pub-id pub-id-type="pmid">20148674</pub-id></mixed-citation></ref><ref id="pone.0161400.ref028"><label>28</label><mixed-citation publication-type="journal"><name><surname>Vincent</surname><given-names>HK</given-names></name>, <name><surname>Taylor</surname><given-names>AG</given-names></name>. <article-title>Biomarkers and potential mechanisms of obesityinduced oxidant stress in humans</article-title>. <source>Int J Obes (Lond)</source>. <year>2006</year>;<volume>30</volume>:<fpage>400</fpage>&#x02013;<lpage>18</lpage>.<pub-id pub-id-type="pmid">16302012</pub-id></mixed-citation></ref><ref id="pone.0161400.ref029"><label>29</label><mixed-citation publication-type="journal"><name><surname>Frohnert</surname><given-names>BI</given-names></name>, <name><surname>Sinaiko</surname><given-names>AR</given-names></name>, <name><surname>Serrot</surname><given-names>FJ</given-names></name>, <name><surname>Foncea</surname><given-names>RE</given-names></name>, <name><surname>Moran</surname><given-names>A</given-names></name>, <name><surname>Ikramuddin</surname><given-names>S</given-names></name>
<etal>et al</etal>
<article-title>Increased adipose protein carbonylation in human obesity</article-title>. <source>Obesity (Silver Spring)</source>. <year>2011</year>;<volume>19</volume>:<fpage>1735</fpage>&#x02013;<lpage>41</lpage>.<pub-id pub-id-type="pmid">21593812</pub-id></mixed-citation></ref><ref id="pone.0161400.ref030"><label>30</label><mixed-citation publication-type="journal"><name><surname>Pou</surname><given-names>KM</given-names></name>, <name><surname>Massaro</surname><given-names>JM</given-names></name>, <name><surname>Hoffmann</surname><given-names>U</given-names></name>, <name><surname>Vasan</surname><given-names>RS</given-names></name>, <name><surname>Maurovich-Horvat</surname><given-names>P</given-names></name>, <name><surname>Liu</surname><given-names>CY</given-names></name>
<etal>et al</etal>
<article-title>Visceral and subcutaneous adipose tissue volumes are cross-sectionally related to markers of inflammation and oxidative stress: the Framingham Heart Study</article-title>. <source>Circulation</source>. <year>2007</year>;<volume>116</volume>:<fpage>1234</fpage>&#x02013;<lpage>41</lpage>. <pub-id pub-id-type="pmid">17709633</pub-id></mixed-citation></ref><ref id="pone.0161400.ref031"><label>31</label><mixed-citation publication-type="journal"><name><surname>El-Assaad</surname><given-names>W</given-names></name>, <name><surname>Buteau</surname><given-names>J</given-names></name>, <name><surname>Peyot</surname><given-names>ML</given-names></name>, <name><surname>Nolan</surname><given-names>C</given-names></name>, <name><surname>Roduit</surname><given-names>R</given-names></name>, <name><surname>Hardy</surname><given-names>S</given-names></name>
<etal>et al</etal>
<article-title>Saturated fatty acids synergizewith elevated glucose to cause pancreatic beta-cell death</article-title>. <source>Endocrinology</source>. <year>2003</year>;<volume>144</volume>:<fpage>4154</fpage>&#x02013;<lpage>63</lpage>. <pub-id pub-id-type="pmid">12933690</pub-id></mixed-citation></ref><ref id="pone.0161400.ref032"><label>32</label><mixed-citation publication-type="journal"><name><surname>Mayer-Davis</surname><given-names>EJ</given-names></name>, <name><surname>Monaco</surname><given-names>JH</given-names></name>, <name><surname>Hoen</surname><given-names>HM</given-names></name>, <name><surname>Carmichael</surname><given-names>S</given-names></name>, <name><surname>Vitolins</surname><given-names>MZ</given-names></name>, <name><surname>Rewers</surname><given-names>MJ</given-names></name>
<etal>et al</etal>
<article-title>Dietary fat and insulinsensitivity in a triethnic population: the role of obesity. The InsulinResistance Atherosclerosis Study (IRAS)</article-title>. <source>Am J Clin Nutr</source>. <year>1997</year>;<volume>65</volume>:<fpage>79</fpage>&#x02013;<lpage>87</lpage>. <pub-id pub-id-type="pmid">8988917</pub-id></mixed-citation></ref><ref id="pone.0161400.ref033"><label>33</label><mixed-citation publication-type="journal"><name><surname>Stein</surname><given-names>DT</given-names></name>, <name><surname>Stevenson</surname><given-names>BE</given-names></name>, <name><surname>Chester</surname><given-names>MW</given-names></name>, <name><surname>Basit</surname><given-names>M</given-names></name>, <name><surname>Daniels</surname><given-names>MB</given-names></name>, <name><surname>Turley</surname><given-names>SD</given-names></name>
<etal>et al</etal>
<article-title>The insulinotropic potency offatty acids is influenced profoundly by their chain length and degree of saturation</article-title>. <source>J Clin Invest</source>. <year>1997</year>;<volume>100</volume>:<fpage>398</fpage>&#x02013;<lpage>403</lpage>. <pub-id pub-id-type="pmid">9218517</pub-id></mixed-citation></ref><ref id="pone.0161400.ref034"><label>34</label><mixed-citation publication-type="journal"><name><surname>Thomsen</surname><given-names>C</given-names></name>, <name><surname>Rasmussen</surname><given-names>O</given-names></name>, <name><surname>Lousen</surname><given-names>T</given-names></name>, <name><surname>Holst</surname><given-names>JJ</given-names></name>, <name><surname>Fenselau</surname><given-names>S</given-names></name>, <name><surname>Schrezenmeir</surname><given-names>J</given-names></name>
<etal>et al</etal>
<article-title>Differential effects of saturated and monounsaturated fatty acids on postprandial lipemia and incretin responses in healthy subjects</article-title>. <source>Am J Clin Nutr</source>. <year>1999</year>;<volume>69</volume>:<fpage>1135</fpage>&#x02013;<lpage>43</lpage>. <pub-id pub-id-type="pmid">10357731</pub-id></mixed-citation></ref><ref id="pone.0161400.ref035"><label>35</label><mixed-citation publication-type="journal"><name><surname>Borkman</surname><given-names>M</given-names></name>, <name><surname>Storlien</surname><given-names>LH</given-names></name>, <name><surname>Pan</surname><given-names>DA</given-names></name>, <name><surname>Jenkins</surname><given-names>AB</given-names></name>, <name><surname>Chisholm</surname><given-names>DJ</given-names></name>, <name><surname>Campbell</surname><given-names>LV</given-names></name>. <article-title>The relation between insulin sensitivity and the fatty-acid composition of skeletal-muscle phospholipids</article-title>. <source>N Engl J Med</source>. <year>1993</year>;<volume>328</volume>:<fpage>238</fpage>&#x02013;<lpage>44</lpage>. <pub-id pub-id-type="pmid">8418404</pub-id></mixed-citation></ref><ref id="pone.0161400.ref036"><label>36</label><mixed-citation publication-type="journal"><name><surname>Iggman</surname><given-names>D</given-names></name>, <name><surname>Arnlov</surname><given-names>J</given-names></name>, <name><surname>Vessby</surname><given-names>B</given-names></name>, <name><surname>Cederholm</surname><given-names>T</given-names></name>, <name><surname>Sj&#x000f6;gren</surname><given-names>P</given-names></name>, <name><surname>Riserus</surname><given-names>U</given-names></name>. <article-title>Adipose tissue fatty acids and insulin sensitivity in elderly men</article-title>. <source>Diabetologia</source>. <year>2010</year>;<volume>53</volume>:<fpage>850</fpage>&#x02013;<lpage>7</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1007/s00125-010-1669-0">10.1007/s00125-010-1669-0</ext-link></comment>
<pub-id pub-id-type="pmid">20127308</pub-id></mixed-citation></ref><ref id="pone.0161400.ref037"><label>37</label><mixed-citation publication-type="journal"><name><surname>Vessby</surname><given-names>B</given-names></name>, <name><surname>Uusitupa</surname><given-names>M</given-names></name>, <name><surname>Hermansen</surname><given-names>K</given-names></name>, <name><surname>Riccardi</surname><given-names>G</given-names></name>, <name><surname>Rivellese</surname><given-names>AA</given-names></name>, <name><surname>Tapsell</surname><given-names>LC</given-names></name>
<etal>et al</etal>
<article-title>Substituting dietary saturated for monounsaturated fat impairs insulin sensitivity in healthy men and women: The KANWU Study</article-title>. <source>Diabetologia</source>. <year>2001</year>;<volume>44</volume>:<fpage>312</fpage>&#x02013;<lpage>9</lpage>. <pub-id pub-id-type="pmid">11317662</pub-id></mixed-citation></ref><ref id="pone.0161400.ref038"><label>38</label><mixed-citation publication-type="journal"><name><surname>Wang</surname><given-names>X</given-names></name>, <name><surname>Chan</surname><given-names>CB</given-names></name>. <article-title>n-3 polyunsaturated fatty acids and insulin secretion</article-title>. <source>J Endocrinol</source>. <year>2015</year>;<volume>224</volume>:<fpage>R97</fpage>&#x02013;<lpage>106</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1530/JOE-14-0581">10.1530/JOE-14-0581</ext-link></comment>
<pub-id pub-id-type="pmid">25486966</pub-id></mixed-citation></ref><ref id="pone.0161400.ref039"><label>39</label><mixed-citation publication-type="journal"><name><surname>Salas-Salvado</surname><given-names>J</given-names></name>, <name><surname>Bullo</surname><given-names>M</given-names></name>, <name><surname>Babio</surname><given-names>N</given-names></name>, <name><surname>Martinez-Gonzalez</surname><given-names>MA</given-names></name>, <name><surname>Ibarrola-Jurado</surname><given-names>N</given-names></name>, <name><surname>Basora</surname><given-names>J</given-names></name>
<etal>et al</etal>; <collab>PREDIMED Study Investigators</collab>. <article-title>Reduction in the incidence of type 2diabetes with the Mediterranean diet: results of the PREDIMED-Reus nutrition intervention randomized trial</article-title>. <source>Diabetes Care</source>. <year>2011</year>;<volume>34</volume>:<fpage>14</fpage>&#x02013;<lpage>9</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.2337/dc10-1288">10.2337/dc10-1288</ext-link></comment><pub-id pub-id-type="pmid">20929998</pub-id></mixed-citation></ref><ref id="pone.0161400.ref040"><label>40</label><mixed-citation publication-type="journal"><name><surname>Cocco</surname><given-names>T</given-names></name>, <name><surname>Di Paola</surname><given-names>M</given-names></name>, <name><surname>Papa</surname><given-names>S</given-names></name>, <name><surname>Lorusso</surname><given-names>M</given-names></name>. <article-title>Arachidonic acid interaction with the mitochondrial electron transport chain promotes reactive oxygen species generation</article-title>. <source>Free Radic Biol Med</source>. <year>1999</year>;<volume>27</volume>:<fpage>51</fpage>&#x02013;<lpage>9</lpage>. <pub-id pub-id-type="pmid">10443919</pub-id></mixed-citation></ref><ref id="pone.0161400.ref041"><label>41</label><mixed-citation publication-type="journal"><name><surname>Espinosa</surname><given-names>A</given-names></name>, <name><surname>Garcia</surname><given-names>A</given-names></name>, <name><surname>Hartel</surname><given-names>S</given-names></name>, <name><surname>Hidalgo</surname><given-names>C</given-names></name>, <name><surname>Jaimovich</surname><given-names>E</given-names></name>. <article-title>NADPH oxidase and hydrogen peroxide mediate insulin-induced calcium increase in skeletal muscle cells</article-title>. <source>J Biol Chem</source>. <year>2009</year>;<volume>284</volume>:<fpage>2568</fpage>&#x02013;<lpage>75</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1074/jbc.M804249200">10.1074/jbc.M804249200</ext-link></comment>
<pub-id pub-id-type="pmid">19028699</pub-id></mixed-citation></ref><ref id="pone.0161400.ref042"><label>42</label><mixed-citation publication-type="journal"><name><surname>Delarue</surname><given-names>J</given-names></name>, <name><surname>Couet</surname><given-names>C</given-names></name>, <name><surname>Cohen</surname><given-names>R</given-names></name>, <name><surname>Brechot</surname><given-names>JF</given-names></name>, <name><surname>Antoine</surname><given-names>JM</given-names></name>, <name><surname>Lamisse</surname><given-names>F</given-names></name>. <article-title>Effects of fish oil on metabolic responsesto oral fructose and glucose loads in healthy humans</article-title>. <source>Am J Physiol</source>. <year>1996</year>;<volume>270</volume>:<fpage>E353</fpage>&#x02013;<lpage>62</lpage>. <pub-id pub-id-type="pmid">8779959</pub-id></mixed-citation></ref></ref-list></back></article>